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Most described bacteriophages end their replication cycle by lysing their hosts. This characteristic 
has attracted researchers all over the world aiming to develop new alternatives to fight bacterial 
infectious diseases. All double stranded DNA phages achieve lysis by synthesizing two essential 
proteins: an endolysin, a protein with peptidoglycan hydrolase activity, and a holin, a small 
membrane protein that disrupts the cytoplasmic membrane and allows the access of the endolysin 
to its target or its activation. Holins have been described as essential to determine the optimum 
timing of lysis, so that the phage release is productive for phage survival. In addition to the 
endolysin and holin genes, new genes have been identified in the lysis cassette of bacteriophages 
that infect Gram-negative bacteria. These genes, exemplified by the λ Rz and Rz1 encoded 
proteins that compromise the stability of the outer membrane, eliminating the last barrier to the 
release of the progeny virions. No homologues of Rz/Rz1 genes have been identified in 
mycobacteriophage genomes. The lytic cassette of  mycobacteriophage Ms6, a phage that infects 
Mycobacterium smegmatis cells, comprises, in addition to an endolysin and a holin, three 
accessory lysis proteins encoded by genes gp1, gp3 (lysB) and gp5. Despite being classified as 
Gram-positive bacteria, mycobacteria have a complex cell wall. This cell wall consists of 
peptidoglycan covalently linked to arabinogalactan, which is in turn esterified to a variety of long 
chain (C60–C90), α-branched, β-hydroxy fatty acids (mycolic acids).  
The present work describes the characterization of the protein encoded by the mycobacteriophage 
Ms6 gene lysB and its role in mycobacteria lysis. A BLAST search within the sequences of 
protein databases revealed similarities to other putative proteins encoded by mycobacteriophages. 
After His6-LysB protein production in E. coli, it was possible to test its activity in several 
lipolytic enzymes substrates. Bioinformatics analysis revealed the presence of a conserved motif 
(GYSQG), characteristic of enzymes with lipolytic activity. The results show that LysB is indeed 
a lipolytic enzyme showing higher affinity towards substrates of longer chain length (C16 and 
C18). It is demonstrated that the natural substrates of LysB are mycobacterial lipids containing 
mycolic acids and that that its main target is mycolyl-arabinogalactan peptidoglycan complex, as 
it was shown to release mycolic acids from mAGP. Additionally, LysB is also able to hydrolyze 
the trehalose 6,6’-dimycolate (TDM) from both fast and slow growing mycobacteria species. 
Construction of a mycobacteriophage Ms6 ΔlysB demonstrated that the gene product of lysB is 
nonessential for phage viability, but is involved in the lysis mechanism. Given the complexity of 
the mycobacterial cell envelope, it is easy to understand why mycobacteriophages have evolved 
new lysis strategies by acquiring them through their evolution. 
Key words: Mycobacteriophage Ms6, phage lysins, lipolytic enzymes; mycolic acids 
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A maioria dos bacteriófagos descritos na literatura são capazes de terminar um ciclo de replicação 
lisando as suas células hospedeiras. Esta característica tem atraído os investigadores no sentido de 
explorar esta propriedade para desenvolver novas alternativas para combater doenças infecciosas 
de origem bacteriana. Todos os bacteríofagos de cadeia dupla de DNA atingem a lise através da 
síntese de 2 proteínas essenciais: uma endolisina, uma proteína com actividade de hidrólise, e 
uma holina. Proteína de pequenas dimensões que destrói a membrana citoplasmática permitindo 
que a endolisina aceda ao seu substrato ou seja activada. As holinas estão descritas como sendo 
essenciais para determinar o tempo óptimo da lise, de modo a que a libertação de fagos seja 
produtiva para a sobrevivência do fago. Para além destas duas proteínas essenciais, têm sido 
identificados novos genes nas cassetes de lise de bacteriófagos que infectam bactérias Gram-
negativa. Estes genes, exemplificados pelas proteínas Rz e Rz1 codificadas pelo bacteriófago λ, 
comprometem a estabilidade das proteínas da membrana externa, eliminando a última barreira 
para a libertação dos viriões produzidos. Até à data nunca foram identificados homólogos destes 
genes em micobacteriófagos. A cassete lítica do micobacteriófago Ms6, fago que infecta 
Mycobacterium smegmatis, para além de codificar as duas proteínas essenciais, compreende três 
proteínas acessórias à lise codificadas pelos genes gp1, gp3 (lysB) e gp5, restritos aos 
micobacterófagos. Apesar de serem classificadas com bactérias Gram-positivas, as micobactérias 
apresentam uma parede celular complexa. Esta parede celular consiste num peptidoglicano ligado 
covalentemente ao arabinogalactano, que por sua vez se encontra esterificado a uma variedade de 
ácidos gordos de cadeia longa (ácidos micólicos).  
A presente dissertação caracteriza a proteína codificada pelo gene lysB do micobacteriófago Ms6 
e o seu papel durante a lise. A análise bioinformática revelou a presença de um motivo 
conservado (GYSQG), característico de enzimas com actividade lipolítica. Usando a sequência de 
aminoácidos de LysB, foi realizada uma procura de similaridades nas bases de dados, através do 
programa BLAST, que identificou um grande número de proteínas similares. Após produção de 
uma proteína recombinante, His6-LysB, em E. coli foi possível testar a sua actividade em 
diferentes substratos de enzimas lipolíticas. Os resultados demonstraram que LysB apresenta uma 
maior afinidade para substratos de cadeia longa (C16 e C18). Foi possível demonstrar que o alvo de 
Ms6 LysB é a membrana externa de Mycobacterium smegamtis, ao clivar a ligação ester que liga 
os ácidos micólicos ao arabinogalactano no complexo micolil-arabinogalactano peptidoglicano. 
No entanto este substracto não é único uma vez que LysB também é capaz de hidrolisar o 6,6’-
trealose dimicolato (TDM) de diferentes espécies de micobactérias. A construção de um 
micobacteriófago delecionado no gene lysB, demonstrou que o produto deste gene não é essencial 
xv 
 
para a viabilidade do fago, mas participa no mecanismo de lise. Tendo em conta a complexidade 
do envelope das micobactérias, é fácil entender a necessidade dos micobacteriófagos adquirirem, 
durante a sua evolução, genes que lhes conferem uma vantagem evolutiva sobre aqueles que não 
os adquiriram de modo a conseguirem atingir uma lise mais rápida e eficiente. 
Palavras Chave: Micobacteriófago Ms6, lisinas fágicas, enzimas lipolíticas; ácidos micólicos 
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1. The Mycobacterium genera 
The Mycobacterium genera include more than 100 species and belong to the Mycobacteriaceae 
family, order Actinomycetales, a large group of Gram-positive bacteria containing GC-rich 
DNA. Within this group, mycobacteria belong to one branch, called the Corynebacterium-
Mycobacterium-Nocardia (CMN) branch. Mycobacteria can be distinguished between fast 
growing (generation time 3-5h) and slow growing (generation time 18-24h) species. Most of the 
species are saprophytic soil bacteria and a minority, belonging to the Mycobacterium. 
tuberculosis complex, is pathogenic to humans, causing old known diseases such as tuberculosis 
and leprosy (Jarlier & Nikaido, 1994). Tuberculosis (TB), also known as the white plague, is 
caused by the slow growing species Mycobacterium tuberculosis. It received the title of “captain 
of all these men of death” by John Bunyan in the second half of the XVII century, when the 
disease reached a high level of death rates in Europe. This disease became the principal cause of 
death by the end of the XIX and beginning of the XX century, and among its various victims 
were worldwide known people, such as Frédéric Chopin, Paganini, St. Francis of Assisi, Lord 
Byron and Elenor Roosevelt (Ducati et al., 2006). Currently, this disease still represents a global 
threat, as it stands as the leading cause of death due to an infectious agent among adults 
worldwide with 1.1 million deaths and an estimated 8.9 million incident cases in 2010 (WHO 
Report 2011). In 2010, the Portuguese Health Authorities reported a TB incidence of 22 cases 
per 100,000 people nationwide (Antunes, 2010), being the European country with the higher 
incidence rate. The problematic of tuberculosis is worsened by the increasing incidence of MDR 
(multiple drug-resistant) tuberculosis, defined as strains that are resistant to isoniazid and 
rifampicin (Telenti & Iseman 2000), and more recently XDR (extensively drug-resistant) which 
means that these strains in addition to being resistant to isoniazid and rifampicin, are also 
resistant to any member of the quinolone family and at least to one of the second-line anti-
tuberculosis injectable drugs (CDC 2006). Leprosy, a chronic disease with an estimated 250.000 
new cases annually is cause by M. leprae (Koremromp et al., 2009). Nontuberculosis 
mycobacteria, like the Mycobacterium avium complex, Mycobacterium kansasii, 
Mycobacterium fortuitum, and Mycobacterium chelonae, cause severe disease in 
immunodeficient individuals, such as those with AIDS or cystic fibrosis however, disseminated 
infections can also appear in healthy individuals (Al-Muhsen & Casnova 2008). 
One of the major differences of mycobacteria is their unique cell wall structure (Fig. 1). The 
chemical nature of the mycobacteria envelope is different from those of Gram-negative and 
Chapter 1 
 
Gram-positive bacteria, with a lipid content that may represent up to 60% (Neyrolles & Guilhot 
2011) of the cell dry mass, compared to 5-10% in Gram-positive and Gram-negative bacteria 
(Goren & Brennan 1979). This high lipid content accounts for a high hydrophobicity that 
contributes to the low permeability to nutrients and antibacterial drugs, which slows down the 
growth of mycobacteria and makes disease caused by pathogenic species difficult to treat 
(Jarlier & Nikaido 1990). Another distinguishing property shared among mycobacteria is the 
fact that their cell wall retains carbol fuchsin dye even in the presence of acidic alcohol, for this 
reason mycobacteria are also known as acid fast bacilli (Glickman & Jacobs 2001).  
1.1. The mycobacteria envelope 
The envelope of mycobacteria consists of the cytoplasmic membrane surrounded by the cell 
wall core which is composed of peptidoglycan (PG) covalently attached to arabinogalactan 
(AG), which is, in turn is attached to the mycolic acids forming the mycolyl arabinogalactan-
peptidoglycan (mAGP) complex (Brennan, 2003). These covalently linked mycolic acids 
comprise all or part of the inner layer of a true outer membrane (Hoffman et al., 2008; Zuber et 
al., 2008). Finally, outside of the outer membrane is a layer of protein and polysaccharides 
known as the capsule (Lemassu & Daffé 1994; Lemassu et al., 1996). The plasma membrane is 
structurally and functionally similar to other bacterial cytoplasmic membranes (Silva & Macedo 
1983; Daffe et al., 1989), where polar lipids, mainly phospholipid, assemble themselves, in 
association with proteins, into a lipid bilayer (Ortalo-Magné et al., 1996b) and are almost 
invariably derivatives of phosphatidic acid. The most common phospholipids of the cytoplasmic 
membrane are the phosphatidylinositol mannosides (PIM), phosphatidylglycerol, cardiolipin 
and, phosphatidylethanolamine (Ortalo-Magné et al., 1996b). Other components associated with 
the cytoplasmic membrane include a number of polyterpene-based products thought to be 
associated with protection against photolytic damage, such as the carotenoids, and the 
menaquinones that are involved in electron transport (Brennan, 1988). 
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Figure 1. Cell envelopes of bacteria. A) Gram-positive bacteria; B) Gram-negative bacteria; C) Mycobacteria. 
Abbreviations: PIM, fosfatidilmio-inositol manoside; LPS, Lipopolissacaride. A) and B) adapted from Nikaido et al., 
1994; C) adapted from Sherman, M. (unpublished work). 
The carotenoids of mycobacterial are responsible for the characteristic yellow-orange color of 
photochromogenic mycobacterial such as M. gordonae and M. kansasii (Brennan & Nikaido 
1995).  
Although mycobacteria are classified as Gram-positive bacteria, the existence of a compartment 
analogous to the periplasmic space in Gram-negative bacteria has been proposed by Daffé & 
Drapper (1998). Recent advances in deciphering the structure of the mycobacteria cell envelope 
confirm the existence of a periplasmic space in (Hoffman et al., 2008; Zuber et al., 2008; Sani 
et al., 2010).  
The peptidoglycan consists of alternating units of N-acetylglucosamine and N-glycolylmuramic 
acid cross-linked by tetrapeptides chains (Besra & Brennan 1997). The structure of 
mycobacterial peptidoglycan is slightly different from that of the common type. Many of the 
muramic acid residues are N-glycolylated with a glycolyl residue rather than the usual acetyl 
residue (Uchida & Aida 1979). In mycobacteria, except in M. leprae, the peptide chain consists 
of L-alanine-D-isoglutamic acid-diaminopimelic acid-D-alanine and the diaminopimelic acid is 
amidated (Mahapatra et al., 2005). The amino acids cross-link is between residues of 
diaminopimelic acid or between diaminopimelic acid and D-alanine (Azuma et al., 1970). The 
peptidoglycan is covalently bound to arabinogalactan, a complex branched heteropolysaccharide 
that contains a galactan chain composed of altering 5- and 6-linked D-galactofuranosyl residues 
(McNeil & Brennan, 1991) to which two arabinan chains of 20-31 residues each are attached 
(Bhamidi et al., 2011). The terminal pentaarabinoside is in turn esterified by long chain (C60-
C90) α-alky, β-hydroxy fatty acids, the mycolic acids (Brennan & Nikaido 1995; Bhamidi et al., 
2011). Two families of mycolic acids are known: α mycolates without any oxygenated 
functional groups and the oxygenated mycolates. Slow-growing pathogenic mycobacteria such 
as M. tuberculosis modify their mycolic acids by introducing cyclopropane rings 
(cyclopropanation), whereas fast-growing saprophyte species such as M. smegmatis do not 
(Chatterjee, 1997). These fatty acids constitute a significant proportion of the mass of the cell 
wall core and form a hydrophobic permeability barrier that surrounds the bacterium through 
hydrophobic interaction (Minnikin 1982; Brennan & Nikaido 1995). This feature is responsible 
for part of the endogenous resistance of M. tuberculosis to many drugs (Jarlier & Nikaido 1994; 
Drapper 1998). It has recently been shown that mycolic acids fold in a 4 column “W” 
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confirmation both by physical methods (Villeneuve et al., 2005; Villeneuve et al., 2007) and by 
the dimension of the outer membrane (Hoffman et al., 2008; Zuber et al., 2008). 
The existence of this outer membrane bilayer has long been postulated (Minnikin, 1982) but 
only recently has been demonstrated in various mycobacterial species, through the direct 
visualization of vitreous sections under a cryo-electron microscope (Hoffmann et al., 2008; 
Zuber et al., 2008). 
Embedded somehow in the cell wall core is a variety of extractable of lipids, like the glycolipids 
that are synthesized by all cultivable mycobacterial species, such as trehalose monomycolate 
(TMM), trehalose dimycolates (TDM), while others like sulfolipids (SL), phenolglycolipids 
(PGL), di- and tri-acyl trehaloses (DAT and TAT), glycopeptidolipis (GPL) and phthiocerol 
dimycocerosates (DIM) (Asselineau, 1998), are limited to specific species. Many of these are 
suspected to be present in the outer leaflet of the outer membrane and biosynthetically it is 
logical that TMD and TDM are present in the inner leaflet of the outer membrane as well as 
being present in the outer leaflet as these two glycolipids are the source of the mycolic acids 
attached to the arabinosyl residues of the cell wall core. 
Also, interspersed somehow are the cell wall proteins, and the lipid anchored polysaccharides 
such as lipomannan (LM) and lipoarabinomannan (LAM). LAM is exposed on the surface and 
directly implicated in the immunopathogenesis of leprosy and tuberculosis (Brennan et al., 
1990). Thus LAM and LM may be anchored in the plasma membrane or the outer membrane or 
both; the available information is ambiguous on their location (Ortalo-Magné et al., 1996a). The 
phosphatidylinositol manosides (PIMs which are essentially the lipid anchor regions of LM and 
LAM with only minimal additional glycosylation) have long been thought to be present in the 
plasma membrane but may also be present in the outer membrane. Finally, the phthiocerol-
containing lipids, which lack a polar head group are known to be exported from the inside of the 
cell (Cox et al., 1999) but the extracellular location is to be known. In mycobacteria, the 
presence of a low number of pore forming proteins relatively to Escherichia coli may explain 
the low permeability and the low susceptibility to toxic agents (Niederweis, 2003). 
The occurrence of a capsule surrounding this outer membrane, has now been well established by 
Ortalo-Magné et al. (1995) who first analyzed the composition of the putative capsule 
established that the main components were polysaccharides and proteins, with much smaller 
amount of lipid. In 2010, Sani et al. demonstrated the presence of a capsule in both pathogenic 
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and non-pathogenic mycobacteria (including M. smegmatis, M. marinum and M. tuberculosis). 
In M. marinum this capsular layer, in addition to containing arabinogalactan, glycan and 
mannose-containing glyco-lipids, also surprisingly contains a large amount of ESX-1-secreted 
proteins. 
More recently, there has been an urgent need for new antituberculosis drugs to combat the high 
incidence of drug resistant disease. Bacterial envelopes are, in general, essential for survival 
under normal conditions. Since mycobacteria envelopes contain many unique structures, they 
are obvious targets for novel drugs, and this led to renewed interest in structures and 
biosynthetic pathways. 
 
2. Bacteriophages 
Bacteriophages constitute a group of viruses that specifically infect bacteria. They are known to 
attack over 150 bacterial genera (Ackerman, 2009). Bacteriophages, as bacteria, are very 
common in all natural environments and it is estimated that there are about 1031 phages on earth 
and approximately 5500 have been characterized and reported (Ackerman, 2009). 
Bacteriophages are universally observed in open and coastal waters, marine sediments, 
terrestrial ecosystems such as soil, and the bodies of humans, animals and insects (Ackerman, 
2003). They are not only the most abundant biological entities but probably also the most 
diverse ones and are characterized by a high degree of mosaicism that likely arises from 
extensive horizontal genetic changes (Hendrix et al., 1999; Hendrix, 2003, Hatfull, 2008). The 
majority of the sequence data obtained from phage communities has no equivalents in 
databases. The phage population is dynamic, turning over rapidly through constant attrition and 
subsequent amplification in permissive host (Pedulla et al., 2003). According to the 
International Committee on Taxonomy of Virus, bacteriophages classification includes 1 order 
and 14 families and 37 genera (Fauquet et al., 2005). Bacteriophages are composed of a protein 
shell, the capsid, often in the shape of icosahedrons. The capsid encloses the viral genome, 
which can be ssDNA (single-stranded DNA), dsDNA (double-stranded DNA), ssRNA (single-
stranded RNA) or dsRNA (double-stranded RNA) with most known bacteriophages having 
dsDNA. The majority of phages carry a more or less complex tail to which a base plate, spikes, 
or tail fibers can be attached. These structures are involved in recognition and attachment to 
phage receptors present at the bacterial surface. It was noticed that 5280 out of the 5500 
reported phages are tailed phages, which are composed of an icosahedral head and a tail 
(Ackerman, 2009). Tailed phages are dsDNA phages and belong to three families according to 
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the morphological features of the tail: Myoviridae (contractile tail), Siphoviridae (long 
noncontractile tail) being the most abundant family including 61% of the phages described, and 
Podoviridae (extremely short tail). The rest of the phages, constituting only 4% of the total, are 
classified into 11 families. They are cubic, filamentous, or pleomorphic phages with dsDNA, 
ssDNA, dsRNA, or single-stranded RNA (ssRNA) genome and some types contain lipids in 
their envelopes or internal constituents (Ackerman, 2009).  
Except for filamentous phages, which continuously extrude from their hosts without causing 
host lysis, all other phages are lytic phages that encode gene products to compromise or destroy 
the bacterial cell wall, leading to bacteriolysis (Young, 2005). For phages that end their 
vegetative cycle by lysing their hosts, disruption of the host cell wall may be accomplished in 
two ways: i) tailed phages use the holin-endolysin strategy to hydrolyze the bacterial murein 
layer; ii) phage lacking tails synthesize a single lytic factor that compromises the strength of the 
cell wall (Young, 2005). 
According to their type of life cycle, dsDNA phages can be classified into virulent or temperate 
(Fig. 2). Virulent phages follow a lytic cycle that ends with lysis and death of the host bacteria 
cell, whereas temperate phages may follow a lytic or a lysogenic cycle. Phage infection starts 
with adsorption to specific receptors on the bacterial cell and the host specificity of the phage is 
usually determined by the type of tail fibers that a phage has. The nature of the bacterial 
receptor varies for different bacteria. Examples include proteins on the outer surface of the 
bacterium, teichoic acids, lipopolysaccharides, polysaccharides and lipoprotein (Rakhuba et al., 
2010). Adsorption is followed by transfer of phage genome into the host cell. The viral genome 
is generally transcribed by host cell RNA polymerase, producing early mRNA that has the 
effect of taking over the metabolic machinery of the bacterium, redirecting its metabolic 
processes to the manufacture of new virus components. These components are then assembled 
into complete virions. Once the new phage particles are formed, cell lysis occurs in order to 
liberate the new virions, which are now able to infect neighbor host (Young et al., 2000).  
In the lysogenic cycle the phage DNA may integrate into the host genome and spend part of 
their life cycle in a quiescent state called prophage but may also exist as a plasmid. Prophage 
DNA will be replicated when the host cell genome replicates and so daughter cells will inherit 
the viral DNA. Bacterial cells containing prophages – lysogenic cells – may undergo several 
rounds of division but occasionally one will spontaneously lyse and liberate progeny phage. 
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Alternatively, a population of lysogenic cells may be induced to lyse by subjecting them to 
stress, such as treatment with mutagenic agents or exposure to ultraviolet light, and undergo a 
lytic cycle with the release of phage progeny (Ranquet et al., 2005). 
Phage 
Lytic cycle 
induction 
Lytic PathwayLysogenic Pathway 
Celular division 
Bacterial cell 
Bacterial chromosome 
Adsorption and DNA injection 
DNA circularization 
Phage DNA 
integration into the 
host chromosome 
DNA replication 
Synthesis of viral 
components 
Late protein synthesis 
Lysis of bacterial cell and release 
of phage progeny 
Phage DNA integrated replicates with the 
bacterial DNA 
Prophage 
Early mRNA and protein synthesis 
 
 
 
 
 
 
 
 
 
 
Figure 2. Lytic and lysogenic cycles exemplified by bacteriophage λ. See text for more complete description. Figure 
adapted from Hanlon, 2007. 
 
3. Strategies for host lysis 
As mentioned above, the final stage of a phage vegetative cycle is the release of newly 
synthesized phage particles. This is an important step regarding phage survival and ecological 
fitness. A sharply time-defined and efficient release of phage progeny is crucial to maximize 
both the burst-size (number of phages that are produced per phage-infected bacterium) and the 
opportunity to infect new hosts (São José et al., 2007). The main barrier of host lysis is the 
continuous meshwork of peptidoglycan so compromising the cell wall is thus the fundamental 
goal for lytic processes (Young et al., 2000). 
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3.1. Phages with single-stranded genomes 
Unlike most of the well-studied phages, which have large dsDNA genomes, lysis strategy of 
small single-stranded genomes (ssDNA or ssRNA, fewer than 6kb) is poorly understood 
(Bernhardt et al., 2002a). These phages developed a lysis mechanism with a single lytic protein 
(Young, 1992) probably because of the limited coding capacity of their small-size genomes. In 
these cases, the lysis activity appears to have evolved late, after the replicative and 
morphogenesis functions, because it is either a secondary activity of a morphogenesis protein or 
is encoded in a short alternate reading frame embedded in an essential morphogenetic cistron 
(Young, 2000). These lysis proteins act as “protein antibiotics”, inhibiting cell wall synthesis 
and promoting septal catastrophe as the cell attempts division (Bernhardt et al., 2002a). The 
only well characterized phages of this class are coliphages and among them there are three 
different prototypical lysis proteins: 1) the L protein of the ssRNA bacteriophage MS2 
(Leviviridae), 2) the E protein of the single-stranded ssDNA bacteriophage φX174 
(Microviridae), and 3) the A2 protein of the ssRNA bacteriophage Qβ (Alloleviviridae) 
(Bernhardt et al., 2002a).  
Phage φX174 lysis gene, E, and phage Qβ lysis gene, A2, encode proteins that specifically 
inhibit enzymes in the host murein synthesis pathway, while protein E inhibits the phospho-N-
acetylmuramoyl-pentapeptide transferase (MraY) an integral membrane protein (Bernhardt et 
al., 2001a; Mendel et al., 2006), that catalyzes the synthesis of the first lipid-linked intermediate 
in peptidoglycan synthesis (Bernhardt et al., 2000; Bernhardt et al., 2001a), the Qβ A2 inhibits 
the UDP-N-acetylglucosamine enolpyruvyl transferase (MurA), a soluble enzyme catalyzing the 
first step of murein precursor synthesis, respectively (Bernhardt et al., 2001b). However, the 
function of the MS2 lysis protein, L, remains unknown. Since at least two out of three 
prototypical lysis proteins of small phages inhibit a specific step in peptidoglycan synthesis, this 
may be a general lysis strategy employed by many ssDNA and ssRNA phages of limited 
genome size. No muralytic enzyme activity has been detected in the lysates of these phages, and 
the analysis of their sequence does not revealed the presence of any muralytic enzyme. Based 
upon their activity, the term amurin, to indicate their negative effect on murein synthesis, has 
been proposed to identify this class of lysis proteins (Young 2002). 
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3.2. Phages with double-stranded DNA genomes 
dsDNA phages encode two proteins that have independently evolved to accomplish both rapid 
progeny release and optimal lysis time. One of these proteins is an endolysin, a peptidoglycan 
hydrolase, which is a soluble, non-structural component of the virion. The other protein 
involved in lysis is the holin, which is responsible for defining the optimal timing for lysis and 
is also responsible for either the endolysin activation or the endolysin access to the 
peptidoglycan. Evolutionary speaking, time-defined lysis is advantageous to the phage and it is 
a trait under high selective pressure depending on host fitness and abundance (Wang et al., 
1996; Wang 2006). 
3.3. Proteins involved in phage lysis 
3.3.1. Endolysins 
The name endolysin was coined in 1958 to designate a probably proteinaceous lytic substance 
synthesized in bacterial cells during phage multiplication and acting on the cell wall from inside 
the cell (Jacob & Fuerst, 1958). They are characterized by their ability to directly target bonds in 
the peptidoglycan (PG) of the bacterial cell wall, resulting in the degradation of the murein layer 
and release of newly assembled virions by way of lysis (Loessner, 2005). Endolysins are clearly 
distinguished from the lytic enzymes, since these enzymes are components of the virion and are 
able to digest the cell wall from the outside to allow the phage genome to be injected into the 
host cell.  
Endolysins can be classified according to their catalytic activity as N-acetylmuramidases 
(lysozymes or muramidases), endo-β-N-acetylglucosaminidases (glucosaminidases), 
transglycosylases, N-acetylmuramoyl-L-alanine amidases (NAM-amidases), and 
endopeptidases. Glucosaminidases, lysozymes, and transglycosylases act on the sugar moiety 
(glycosidases) of the peptidoglycan whereas amidases hydrolyze the amide bond between the 
sugar of NAM and L-alanine residues in the oligopeptide crosslinking chains and 
endopeptidases cleave one of several different peptide linkages in the oligopeptide cross-links 
(Fig. 3) (Hermoso et al., 2007). Endolysins usually possess only one type of hydrolytic activity, 
but some enzymes harboring two independent activities have already been reported. Examples 
are the endolysins of phages B30 (Pritchard et al., 2004) and NCTC 11262 (Cheng et al., 2005) 
both infecting Streptococcus agalactiae (endopeptidase and Lysozyme), Staphylococcus aureus 
phage φ11 (endopeptidase and NAM-amidase) (Navarre et al., 1999) and the prophage φWMY 
from Staphylococcus warneri M (endopeptidase and NAM-amidase) (Yokoi et al., 2005).  
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Many endolysins, especially from phages infecting Gram-positive host have a modular 
structure, with a catalytic domain located at the N-terminal, and a cell wall binding domain 
(CWBD) located at the C-terminal end, which may bind a species-specific carbohydrate epitope 
in the cell wall (Hermoso et al., 2007).  
 
Figure 3. Bacterial cell wall structure and endolysin targets. (a) Schematic representation of the bacterial cell wall; 
(b) peptidoglycan structure (gram-positive bacteria) and endolysins targets. Figure from Hermoso et al., 2007. 
Most endolysins are not endowed with N-terminal secretion signals that would allow them to 
cross the cytoplasmic membrane, and are thus dependent on holin function to access their target. 
However, recent findings have shown that some endolysins are exported to the extra-
cytoplasmic environment in a holin independent way. The first report came from the work of 
Parreira et al. (1999), on the Oenococcus oeni phage fog44 (Fig. 4). It was demonstrated that 
the endolysin Lys44 contains an N-terminal cleavable signal-peptide and that is continuously 
exported to the cell wall from the moment of its synthesis, involving the host sec translocon 
(São José et al., 2000). 
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It was proposed that Lyz44 protein is kept in an inactive state in the murein layer, perhaps by 
local conditions that directly inhibit the catalytic site of the enzyme (São José et al., 2000). 
Regardless the fact that the endolysin is secreted to the periplasm, fog44 apparently has a holin 
gene, hol44 (Parreira et al., 1999). A search of orthologous endolysins from phages infecting 
Gram-positive bacteria revealed that some of these endolysins had N-terminal sequences 
resembling secretory signals, and also in every case an adjacent holin gene is predicted. It is 
clear that in these phages the holin is not required for the export of the endolysin but its 
presence suggests that the lysis clock is regulated by holin-mediated membrane disruption that 
would somehow activate the exported endolysin rather than allowing their passage through the 
cytoplasmic membrane (São José et al., 2000). Indeed, Nascimento et al. (2008) have shown 
that bacterial membrane proton-motive force regulates the lytic activity of the secreted 
endolysin Lys44. Experimental evidence for other secreted endolysins has been obtained for the 
lytic enzymes of phages φAM2 (São José et al., 2000) and φg1e (Kakikawa et al., 2002) from 
Lactococcus lactis and Lactococcus plantarum, respectively.  
In addition to these endolysins endowed with a signal peptide, a new class of endolysins named 
SAR (signal-arrest-domain) endolysins was recently identified (Fig. 4). The first description of 
these endolysins results from the work of Xu et al., (2004), on the endolysin of phage P1. The 
N-terminal of P1 Lyz differs significantly from the fOg44 secretory endolysin in that it does not 
have a secretory signal sequence. Instead its N-terminal domain presents a TMD, rich in 
residues that are weakly hydrophobic, functioning as a signal-arrest-release (SAR) sequence. 
The SAR domain engages the sec system directing the endolysin to the periplasm in an inactive 
membrane–tethered form, which is then activated by release from the membrane to a soluble 
state without proteolysis (Xu et al., 2004). Triggering of programmed lysis by the phage holin 
will allow a very rapid, and quantitatively significant, release of the SAR endolysin from the 
membrane which in turn, causes activation of the endolysin leading to a rapid lysis. The SAR 
domain of Lyz has two functions. First, it acts as a signal-arrest sequence and mediates the 
transport, and association, of the phage endolysin to the membrane. Once the protein is released, 
its C13 residue is involved in the isomerisation reaction that relieves topological, covalent, and 
conformational constraints from Lyz, which directs the protein to assume an active 
conformation mediated by DsbA (the periplasmic primary oxidant involved in disulfide bond 
formation), and possibly facilitated by periplasmic foldases and chaperones (Xu et al., 2004; Xu 
et al., 2005). 
It was demonstrated that the exported P1 endolysin is kept inactive by three levels of control -
topological, conformational, and covalent- until its release from the membrane is triggered by 
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the P1 holin (Xu et al., 2005): this functional regulation is essential to avoid premature lysis of 
the infected host. More recently, the regulation of the muralytic enzyme of phage 21 revealed 
that endolysin R also possesses a SAR domain. Both genetic and crystallographic studies show 
that the SAR domain of R21, once extracted from the bilayer, refolds into the body of the 
enzyme and effects muralytic activation by repositioning one residue of the canonical lysozyme 
catalytic triad: besides controlling the topology of protein, the SAR domain in R21 plays a 
specific and more integral role in the catalytic activity of the enzyme. Once synthesized, SAR 
endolysins require both strict post-secretory negative regulation and the means to become 
activated in a timely manner, because they are not sequestered from their substrate by the 
membrane. Inactive LyzP1 has two levels of negative control — covalent inactivation of its 
active-site cysteine and an N-terminal catalytic domain with radical conformational disability —
whereas R21 seems to lack only the correct placement of its catalytic glutamate (Sun et al., 
2009). 
A sequence comparison has identified several endolysins from phages of Gram-negative 
bacteria having N-terminal sequences that resemble the SAR sequences. 57% of the residues in 
the SAR sequences of T4 lysozyme homologs are either weakly hydrophobic Gly and Ala, or 
uncharged polar residues, Ser, Thr, Gln, and Tyr, in contrast to only 36% in a transmembrane 
domain (TMD) (Xu et al., 2004). 
 
 
 
 
 
 
 
 
 
Chapter 1 
 
Figure 4. Model representation of host-lysis strategies of phages producing SAR endolysins or signal peptide-bearing 
endolysins. See text for further description. Figure adapted from São-José et al., 2003.  
3.3.2. Holins 
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Unlike endolysins, holins are much more diverse and frequently unique with respect to their 
primary sequence and they may be defined as small proteins (<150 aa) with at least one 
predicted TMDs, a hydrophilic, highly charged C-terminus and are frequently located 
immediately upstream of a readily identifiable endolysin gene (Wang et al., 2000; Young 2002). 
The high frequency of this particular gene arrangement in phage infecting both Gram-positive 
and Gram-negative bacteria has allowed the tentative assignment of holin functions based on 
sequence analysis alone but predictions may be less straightforward however, if deviations in 
gene arrangement are observed (São José et al., 2003). 
  
 
 
 
Figure 5. Schematic representation of known topologies of described phage holins. Adapted from São-José et al., 
2003. 
Holins have been classified in three different classes I to III according to the predicted or 
experimentally determined number of TMDs, three, two or one, respectively (Wang et al., 
2000). The λ (class I) and T4 (class III) holins are cases where membrane topology has been 
experimentally determined, showing a Nout-Cin and Nin-Cout configuration, respectively (Fig. 5). 
For the holin of lambdoid phage 21 (S21), the prototype of class II holins, it has been suggested a 
Nin-Cin topology (Bläsi & Young 1996; Barenboim et al., 1999). However, some class II 
members may present alternative membrane topologies as suggested for the holin of the 
Clostridium perfringens phage φ3626 holin, for which topology prediction indicates that both 
N- and C-termini face the outside of the membrane (Zimmer et al., 2002). 
Holins are late synthesized proteins, that progressively accumulate in the cytoplasmic 
membrane of the host and while the proton-motive force is maintained, they assemble into 
oligomers and rafts of intrinsic stability (Young & Wang, 2006). Then, at a precise time 
programmed into its primary structure, they suddenly trigger to form a lesion that permeabilizes 
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the membrane. This event ends macromolecular synthesis and thus effectively terminates 
infection (Wang et al., 2000; Young et al., 2000). For canonical holins, the pores are large 
enough to allow the passage of the endolysins accumulated in the cytoplasm. Holins can be 
prematurely triggered by membrane depolarization with energy poisons such as cyanide and 
dinitrophenol (DNP) (Gründling et al., 2001; Young, 2005). So, holin function is thus solely 
directed to the determination of the length of the infective cycle and to allow the endolysin 
access to the peptidoglycan, either by forming pores in the membrane large enough or either by 
activating the endolysins already positioned in the extracytoplasmic compartment. Holins are 
subjected to opposing evolutionary forces; on one hand, there is pressure to extend the 
vegetative cycle to allow continued accumulation virions at a linear rate; on the other hand, 
there is pressure to trigger lysis earlier to release progeny phage particles that can infect new 
hosts and potentially yield exponential increases in phage numbers (Wang et al., 2000; Young 
et al., 2000). 
For phage encoding SAR endolysins, holins need only to depolarize the membrane in order to 
fulfil their role in controlling the timing of lysis. The formation of large membrane lesions like 
those resulting from λS (Wang et al., 2000) would not be necessary. This raises the possibility 
that holins serving SAR endolysins may not function with canonical, soluble endolysins to 
affect host lysis. Indeed, unlike lesions formed by the λ holin, lesions formed by the phage 21 
holin do not allow the passage of λ endolysin (Park et al., 2007). The term ‘‘pinholin’’ has been 
proposed to differentiate the small-hole (pinhole) forming character of the phage 21 holin from 
the canonical holins that form large, nonspecific holes (Park et al., 2007). This pinholin has two 
transmembrane domains, but only TMD2 is required for the pinhole (Park et al., 2006). For both 
canonical holins and pinholins, hole formation occurs suddenly after a period of harmless 
accumulation in the membrane, during which time membrane energization, macromolecular 
synthesis and virion assembly continues undisturbed. Triggering determines the timing of lysis, 
although the molecular strategies are completely different for both (Pang et al., 2009). 
It was suggested that the S21/R21 gene pair, encoding a pinholin and a SAR endolysin, may 
represent an intermediate stage in the evolution of holin-endolysin systems. The minimum 
requirement for an effective phage lysis system, other than the muralytic activity itself, is a 
delay in lysis after the onset of late phage expression, to allow assembly of progeny virions 
(Young & Wang, 2006). The most primitive dedicated lysis system could have consisted of a 
SAR endolysin alone. This mode would provide a lysis delay because of the gradual release and 
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activation of the membrane-tethered endolysins. However, a lysis system employing a SAR 
endolysin alone would be inherently inferior to canonical holin-endolysin systems for two 
reasons. First, because canonical holins function with cytoplasmic endolysins, the muralytic 
activity elaborated during the infection cycle can be produced in great excess. Not only does this 
mean that once the holin triggers, host lysis occurs in a matter of seconds, reducing the dwell 
time in the dead, non-productive host to a minimum, but also it means that lysis timing is 
completely dependent on the holin. Secondly, it has been shown that most missense changes in 
holin proteins alter the timing of lysis, unpredictably advancing or retarding the instant of 
triggering (Raab et al., 1988; Johnson-Boaz et al., 1994; Wang et al., 2000, Rydman et al., 
2003). The canonical holins thus have a selective advantage not only for fitness, in terms of the 
mechanistic advantages of holin function, but also because they can function with either 
cytoplasmic endolysins or SAR endolysins, whereas the pinholin can function only with SAR 
endolysins (Park et al., 2007). 
Although holins appears to be the key factors determining timing of lysis, fine tuning of lysis 
regulation may involve phage proteins with a holin antagonistic function, the antiholins. In fact, 
Young & Bläsi (1995) argued that all phages employing a holin-endolysin system would also 
need an antiholin function as a mean to ensure the post-translational control of holin activity. In 
20 out of 46 cases of phages infecting Gram-positive hosts in which a typical holin-lysin 
cassette was reported, a second holin-like gene, located immediately upstream of the hol-lys 
pair, could be detected (São-José et al., 2003). Also, it cannot be excluded the situation where 
the holin functional unit is built from a complex of different polypeptides, rather than from a 
single protein. The Bacillus subtilis defective prophage PBSX has a late operon, identified as 
the lytic module, composed by the xepA, xhlA, xhlB and xlyA genes, and it was proposed that the 
two open reading frames preceding the endolysin xlyA (xhlA and xhlB) encode polypeptides that 
associate in the membrane to form a functional holin complex that allow XlyA access to the 
peptidoglycan (Longchamp et al., 1994; Krogh et al., 1998).  
Many holin genes have potential dual-start motifs which would allow for the production of a 
shorter holin and a longer antiholin. In fact antiholins have been found to have widely different 
topologies and molecular features: 
‐ On phage λ, the gene encoding the S holin has a dual-start motif which allows the 
production of the holin effector (S105), produced from translation initiation at codon 3, and a 
holin inhibitor (S107 antiholin) resulting from translation initiation at codon 1 (Bläsi et al., 
1989, Bläsi et al., 1990). S105 is a 105-residue integral cytoplasmic membrane protein with 
three TMD topology (Nout, Cin) whereas S107 share the same 105 aa sequence but has an 
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extra Met and Lys residues in the N-terminus that confers two extra positive charges. These 
extra charges prevent the translocation of the first TMD into an energized-membrane 
(Grundling et al., 2000). S105 and S107 are produced in a 2:1 ratio approximately and the 
triggering time of lysis is inversely related to the excess of S105 over S107. When S107 is 
made in excess of S105, lysis does not occur in a physiological meaningful time frame (Raab 
et al., 1988; Bläsi et al., 1990; Chang et al., 1995). When triggering occurs the first hole 
forms, the membranes depolarizes, allowing the N-terminal TMD1 of S107 in each S105-S107 
heterodimer to flip across the membrane; the inactive heterodimers are converted into 
active hole-forming subunits, thus instantly tripling the amount of active holin protein 
involved in compromising the membrane (Young, 2002). 
‐ The P2 lysis cassette spans the genes Y, K, lysA, lysB and lysC, with Y encoding a class I 
holin and K encoding an ortholog of the Rλ endolysin. LysA appears to be an integral 
membrane protein with four TMDs and although non-essential, this protein affect the 
correct timing of lysis as lysA amber mutants causes early lysis and was designated as an 
antiholin. The remaining genes encode functional analogues of λ Rz/Rz1 (Ziermann et al., 
1994). 
‐ T4-infected cells are subjected to “lysis inhibition”, or LIN (Doermann 1948). The LIN 
state, in which the normal lysis timing of the holin is overridden, is established if a T4-
infected cell undergoes superinfection by another T4 particle. In T4 phage the antiholin RI 
is predicted to be either a type II signal anchor protein with an N-terminal TMD, or a 
processed, secreted periplasmic protein (Young, 2005). Superinfection provides a signal 
that causes RI to inhibit T (holin) (Paddison et al., 1998; Tran et al., 2005) and somehow 
shifts the steady state of RI synthesis and degradation in favour of accumulation, allowing 
the formation of RI-T inhibition complexes (Ramanculov & Young, 2001). 
‐ The analysis of P1 of lyd locus indicated that there are two genes, lydAB, under the control 
of a late promoter, with lydA encoding a canonical class I holin and lydB encoding an 
antiholin. These genes are adjacent but unlinked to the endolysin gene, lyz. Unlike the case 
for both λ and T4, the antiholin LydB is essential to obtain a productive burst; in its 
absence, lysis occurs catastrophically early (Walker & Walker, 1980) indicating that LydB 
represses the P1 LydA holin function (Lobocka et al., 2004). 
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There is clearly great diversity in the antiholin schemes evolved by bacteriophages. Presumably 
this reflects the evolutionary impact of achieving lysis ideally timed and consummated to suit 
every variation of the growth environment. Possibly it also reflects the easiness by which holin 
timing can be altered, perhaps by protein-mediated interaction with the holins that distort the 
fragile balance between maintenance of the pre-hole state and the formation of the catastrophic 
lytic lesion (Young, 2002). 
3.3.3. Other proteins involved in lysis – Rz/Rz1 proteins 
The lytic cassette of λ phage comprises the two genes described to be essential for lysis, gene S 
(holin) and the gene R (endolysin) and also two additional genes Rz and Rz1 (Young, 1992).  
λRz encodes a 153 amino acid polypeptide that is predicted to be a type II integral membrane 
protein, with an N-terminal transmembrane domain (TDM) and a periplasmic C-terminus 
(Summer et al., 2007). The Rz1 coding region is embedded entirely within Rz in the +1 reading 
frame (Fig. 6) and is predicted to encode a small (40 aa) proline-rich outer membrane 
lipoprotein lacking similarity to any protein of known function (Summer et al., 2007). In the 
presence of milimolar concentrations of divalent cations, lysis is prevented if both Rz and Rz1 
are inactivated, leading to the accumulation of spherical mechanically fragile cells (Young et 
al.,, 1979; Zhang and Young, 1999). 
Berry et al. (2008) demonstrated that, at physiological levels of expression, Rz and Rz1 are 
localized to inner membrane (IM) and outer membrane (OM) respectively, with their C-terminal 
domains predicted to lie in the periplasm. Recently, it was demonstrated that these two proteins 
form a complex (Berry et al., 2010) and it was proposed their involvement in a third and final 
step in host lysis. The first step is the temporally programmed permeabilization of the 
cytoplasmic membrane by the holin, resulting in the release of a cytoplasmic endolysin or the 
activation of a SAR endolysin. The second stage is the degradation of the peptidoglycan by the 
endolysin. These two stages are followed by a third stage involving the fusion of the IM and 
OM mediated by the Rz/Rz1 complexes. This would cause the cytoplasm and the environment 
to become topologically equivalent and, thus, all conceivable barriers to the release of the 
progeny virions would be eliminated. It was suggested that to facilitate the fusion of the two 
membranes, Rz/Rz1 complexes might undergo conformational changes (Jahn & Scheller, 2006). 
Although this final step is not required in typical laboratory medium lacking sufficient divalent 
cations to stabilize the OM, the lack of Rz or Rz1 function is noticeable as a diminution in the 
sharpness of lysis profiles, not only in lysis mediated by SAR endolysins but also with the 
canonical lambda S/R holin-endolysin lysis (Summer et al., 2007).  
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A bioinformatics search identified Rz/Rz1 equivalents in nearly all genomes from phages that 
infect Gram-negative bacteria (Summer et al., 2007). The variety of Rz/Rz1 equivalents was 
enormous with 37 unrelated gene families grouped in accordance to gene arrangement. In the 
lambda group Rz/Rz1 pairs share the embedded gene architecture (8 families); other the P2 
group, includes families in which Rz1 extends beyond Rz (overlapped structure; 23 families); 
the third group includes families (6 families) with Rz/Rz1 homolog’s encoded in separated 
genes, as exemplified by the T4 pseT.3 and pseT.2 genes, that encode proteins unrelated to all 
other Rz/Rz1 equivalents but that possess the signature N-terminal TMD and outer membrane 
lipoprotein signal sequence respectively (Summer et al., 2007). In the study performed by 
Summer et al., (2007), functional homologous of RZ/RZ1 encoded by a single gene were also 
identified in seven phages, including the coliphage T1. The T1 gp11 and the Rz/Rz1 proteins 
are functionally equivalent. This new class of proteins, named spanins are predicted outer 
membrane lipoproteins that also possess a predicted C-terminal TMD and thus will span the 
entire periplasm, providing a physical link between the inner and outer membranes.  
The fact that genes for Rz/Rz1 equivalents are found in nearly all phages of Gram-negative 
hosts indicates that in the osmotic and ionic conditions found in nature the OM is a significant 
barrier even after holin-endolysin mediated destruction of the cell wall and that they confer an 
advantage in nature that is not apparent under laboratory conditions (Summer et al., 2007). 
While the three steps of phage lysis mediated by holins, endolysins and Rz/Rz1 complexes form 
a sequential pathway, in which holin function is required for endolysin function, which is in turn 
required for Rz/Rz1 function, they are mechanistically independent (i.e. do not require 
heterotypic interactions with each other). This likely accounts for the remarkable diversity and 
mosaicism found in phage lysis cassettes, which are composed of many unrelated families of 
holins and Rz/Rz1 proteins, and at least three types of endolysins (Wang et al., 2000; Young, 
2002; Young and Wang, 2006; Summer et al., 2007). 
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Figure 6. Rz-Rz1 and spanin gene arrangements. In each map, brown, light blue, red and pink boxes indicate holin, 
endolysin, Rz and Rz1 genes, respectively. (A) The prototype embedded (λ, T7), or overlapped (P2) Rz/Rz1 genes. 
(B) Separated Rz and Rz1 genes (VP4 and T4). For phage T4, the start codon for the Rz1 (pseT.2) gene overlaps the 
stop codon of the Rz (pseT.3) gene, although the protein coding sequences are separated. (C) The T1 spanin gene, 
shown as a box with half black and half white filling. Figure adapted from Summer et al., 2007. 
 
4. Phages that infect mycobacteria – Mycobacteriophages 
Mycobacteriophages are viruses that infect mycobacterial hosts. Interest in mycobacteriophages 
began in the late 1940s with the isolation of phages that infect Mycobacterium smegmatis 
(Gardner et al., 1947; Whittaker, 1950), followed by phages that infect Mycobacterium 
tuberculosis (Froman et al., 1954). A primary motivation of these early studies was to type 
mycobacterial clinical isolates, which was further advanced by collecting sizable numbers of 
mycobacteriophages from a variety of environmental and clinical sources (Grange, 1975; Jones, 
1975; Snider et al., 1984). The major interest of these studies was in large part from the medical 
significance and biological idiosyncrasies of their hosts. Some phages like D29, have broad host 
ranges and infect many species of both fast-growing and slowly growing mycobacterial, 
including M. smegmatis and M. tuberculosis (Rybniker et al., 2006), whereas others, like DS-
6A have very narrow preferences and infect only bacteria of the M. tuberculosis complex 
(Redmond & Cater 1960; Rybniker et al., 2006). Several phages discriminate between strains or 
isolates of particular species, and was noted that phage 33D differentiates between BCG strains 
and Mycobacterium bovis (Hatfull, 2010). 
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Realization of the full potential of mycobacteriophages contributes to an understanding of their 
hosts but it requires the characterization of their genomes; the first sequenced genome was that 
of mycobacteriophages L5 in 1993 (Hatfull et al., 1993), followed by D29 and TM4 in 1998 
(Doke, 1960; Donnelly et al., 1993) and Bxb1 in 2000 (Jacobs et al., 1987). Currently, more 
than 1390 mycobacteriophages were already isolated, most of all having M. smegmatis as host. 
The recent advance in the characterization of mycobacteriophages is mainly due to the work of 
Dr. Graham Hatfull, who develops a Phage Hunting program in the University of Pittsburgh 
contributing to the increase in the number of mycobacteriophages isolated. A comparative 
analysis of eighty one complete genome sequences was recently published (Hatfull et al., 2010; 
Henry 2010). All the characterized mycobacteriophages are double-stranded DNA (dsDNA) 
tailed phages belonging to the order Caudovirales, restricted to two morphotypes, the 
Siphoviridae and the Myoviridae (Hatfull et al., 2008).  
4.1. Genomic diversity 
The 81 sequenced mycobacteriophages genomes encompass substantial genetic diversity, and 
the genomic architectures are dominated by mosaic relationships. Any two particular phages 
may share either extensive nucleotide sequence similarity over the entire genome (e.g. phages 
Adjutor and PB11), or as few as three genes whose products share greater than 25% amino acid 
identity (e.g., phages Barnyard and Giles) (Hatfull, 2010). Based on the relationship between 
the genomes, mycobacteriophages were grouped in clusters. The criteria for clustering was that 
any two genomes with evident nucleotide sequence similarity spanning more than 50% of the 
genome lengths should de included within the same cluster. Sequenced mycobacteriophages 
were grouped into nine clusters named A through I and 5 mycobacteriophages have singleton 
genomes with no close relatives. The nine clusters were further subdivided into subclusters, and 
it was anticipated that as additional genomes are sequenced new clusters will be formed and that 
current clusters will undergo further subdivision (Hatfull et al., 2011). 
Hatfull et al. (2006) illustrated the mosaicism of mycobacteriophages genomics by grouping all 
the identified ORFs into “phamilies” of related sequences and then creating phamily circles 
based on their homology. Analysis of the full sequenced genomes allowed assembly of 9014 
putative ORFs into phams, generating a total of 2345 phams, with 1108 phams containing only 
a single gene (orphams) (Hatfull et al., 2011). It is noteworthy that about 15% of 
mycobacteriophages gene phamilies match non-mycobacteriophage sequences, suggesting that 
Chapter 1 
 
new genes are also acquired from bacterial genomes during the course of their evolution 
(Hatfull et al., 2006). Mycobacteriophage genome lengths vary greatly from 41,4 (Angel) to 
164,6 kbp (Myrna) with an average length of 73,6 kbp. The considerable variation in genome 
organization can be demonstrated by mycobacteriophages with a siphovirial morphotype (all but 
Cluster C) since they all share a syntenic group of genes encoding virion structure and assembly 
proteins – as seen in all siphoviruses, regardless of their bacterial host and regardless of the lack 
of sequence similarity. Cluster C consists of mycobacteriophages with myoviral morphologies 
and relatively large genomes, and the virion structure and assembly genes do not appear to be 
organized into a well-defined array as they are in the siphoviruses (Hatfull, 2010). No 
Podoviridae phages have been described, probably due to the thick cell envelope of 
mycobacteria requiring a long tail to insert the DNA into the cytoplasm. 
In summary, a detailed study of mycobacteriophage genes and protein prediction should 
contribute to a better understanding of the phage’s mechanism of infection. This could bring 
new tools for the battle against mycobacterial diseases such as the production of recombinant 
anti-mycobacterial peptides based on the knowledge of key genomics regions such as the lytic 
enzyme cassette, as well as revealing interesting biological features of their unusual bacterial 
hosts (Henry, 2010). 
4.2. Applications and Biotechnology 
We have been assisting, all over the world, to an increase in bacteriophage studies regarding 
their potential as antimicrobial agents against pathogenic bacteria. While the full potential of 
mycobacteriophages has yet to be realized, several useful advances have been made. 
Mycobacteriophages have shown to be powerful tools to study mycobacteria genetics, by 
facilitating the development of mycobacterial genetic systems. Based on the integration systems 
of L5, FRATI and MS6, it was possible to construct integration-proficient plasmid vectors 
(REF). Other applications include methods for mycobacterial transformation (Hatfull, 2005), 
phage-based vectors (e. g., phasmids), non-antibiotic-selectable markers, gene expression 
systems, transposon delivery vehicles (Hatfull, 2000), gene replacement strategies using 
nonreplicating vectors (Husson et al., 1990), long linear DNA fragments (Balasubramanian et 
al., 1996), incompatible plasmids (Pashley et al., 2003), counterselectable markers (Pelicic et 
al., 1996), specialized transducing shuttle plasmids (Bardarov et al., 2002). 
More recently, recombineering systems for mycobacteriophages have been developed by Van 
Kessel et al., (2007) and Marinelli et al., (2008). The bacteriophage recombineering of 
electroporated DNA (BRED) provides for direct genetic manipulation of mycobacteriophages 
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that takes advantage of a mycobacterial-specific recombineering system (Van Kessel et al., 
2007; Marinelli et al., 2008). This recombineering approach is based on the use of the RecET-
like recombination system encoded by phages Che9c, such that expression of genes 60 and 61 
generates high levels of recombination in both M. smegmatis and M. tuberculosis (Van Kessel 
et al., 2007; Van Kessel et al., 2008). The BRED technology thus circumvents major hurdle in 
mycobacteriophages manipulation: providing facile genetic approaches for addressing a 
multitude of questions in mycobacteriophages biology (Hatfull, 2010). 
They have also provided insights into viral diversity and the evolutionary mechanisms that 
generate them and offer potential for the development of novel methodologies for the diagnosis, 
prevention, and treatment of these diseases as well as revealing interesting biological features of 
their unusual bacterial hosts (Hatfull, 2006; Piuri et al., 2009). 
Phage-based systems for the diagnosis of tuberculosis infections have also been described. 
There is currently one commercial manufacturer of phage-based tests on the market, Biotec 
Laboratories Limited (Ipswich, Suffolk, UK), which produces FASTPlaqueTB™ that detects M. 
tuberculosis in sputum samples and FASTPlaque-Response™ that detects rifampicin resistance 
in smear-positive sputum specimens containing M. tuberculosis but even after several 
modifications, the assays are not ready to be used (Trollip et al., 2009). 
Another method employs the use of recombinant mycobacteriophages, such as TM4 and D29, 
carrying the luciferase reporter gene (Jacobs et al., 1993; Sarkis et al., 1995). These FFlux 
reporter phages produce light when they infect M. tuberculosis and can be used to evaluate 
empirical drug susceptibility profiles by inclusion of antibiotics in the assay (Riska et al., 1997; 
Riska et al., 1998; Riska et al., 1999; Banaiee et al., 2001;). All these assays fell short in their 
sensitivity to be used for diagnosis. More recently, a new method for detecting drug resistant 
strains of M. tuberculosis was developed using a TM4 mycobacteriophage phAE87::hsp60-
EGFP (EGFP-phage) engineered to contain the gene encoding a modified Green Fluorescent 
Protein. The method obtained a similar percentage of specificity and sensitivity in detecting 
isoniazid, rifampicin and streptomycin resistance in 155 strains of M. tuberculosis, when 
compared with the proportion method, as the reference standard. The authors suggest that the 
EGFP-phage method has the potential to be a valuable rapid and economic screen for detecting 
drug resistant tuberculosis if the procedure can be simplified (Rondón et al., 2011).  
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Phage-based diagnostic tests are still at an early stage of their development; in future year’s 
further technical innovation may improve their sensitivity, speed or convenience. 
4.3. Mycobacteriophage Ms6 
Ms6 is a temperate mycobacteriophage that infects M. smegmatis with ability to form stable 
lysogens. It was isolated by spontaneously induced M. smegmatis HB5688 (Portugal et al., 
1989; Anes et al., 1992). Ms6 is a double strand DNA phage and the length of the genome is 
over 50 Kb with a GC content of 62%. It is composed of an isometric polyhedral head with 80 
nm in diameter, hexagonal shape, and a long non-contractile tail with 210 nm in length which 
allowed its classification in the Siphoviridae family (Portugal et al., 1989) (Fig. 7). 
 
Figure 7. Mycobacteriophage Ms6 (electron microscopy picture). 
 
Although the complete analysis of the nucleotide sequence is not yet available, some regions are 
already characterized.  The site specific integration locus was identified within a 4.8 kb BglII 
Ms6 DNA fragment. The integrase gene encodes a protein of 372 aminoacids that drives 
integration into the 3’ end of the M. smegmatis tRNAAla gene. The core site, a fragment of 26 
bp, where the recombination between the phage DNA and the bacterial genome occurs is 
positioned 98 bp upstream of the integrase gene (Freitas-Vieira et al., 1998). 
1673 bp downstream of the integrase gene and in the opposite direction, it was identified the 
gene pin coding for a protein involved in a superinfection exclusion mechanism. Work 
developed on the Ms6 Pin protein suggested that expression of this protein did not prevent Ms6 
adsorption but blocks some early step following infection, at a stage between adsorption of the 
phage and DNA injection (Pimentel, 1999). 
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In 2002 Garcia et al., described the genetic organization of the lysis module of 
mycobacteriophage Ms6 following the identification of a strong promoter region (Plys). The 
authors reported that transcription of the lysis genes is driven by two σ70 like promoters that are 
recognized by the host RNA polymerase. A leader sequence of 214 bp was identified between 
this promoter region and the first lysis gene, in which was detected a transcription termination 
signal suggesting that an antitermination mechanism is involved in the regulation of Ms6 lysis 
genes transcription. The DNA sequence of the Plys downstream region revealed the presence a 
lytic cassette composed of five genes, named gp1 through gp5 (Fig. 8). 
 
(A) 
 
 
 
 (B) 
 
Figure 8. (A) Schematic representation of Plys on the 57-kb Ms6 DNA. (B) Genetic organization of the Ms6 lysis 
locus. Figure adapted from Garcia et al., 2002. 
gp1, of 231 bp, encodes a protein of 77 amino acids that was very recently identified as a 
chaperone-like protein (Catalão et al., 2010). Several physical and predicted structural 
characteristics of Gp1 are consistent with those of chaperones, in particular with the type III 
secretion system (TTS) chaperones that although do not exhibit amino acid sequence 
similarities, have in common physical characteristics, including a low molecular weight (< 15 
kDa), an acidic pI (< 5), a predicted amphipathic helix near their C-terminal end and are 
encoded adjacently to their cognate effectors (Page & Parsot 2002; Feldman & Cornelis 2003). 
In addition, Catalão et al., (2010) showed that the Gp1 protein interacts with the N-terminal 
sequence (60 amino acids) of the Ms6 endolysin, its effector. Determination of the growth 
parameters of an Ms6 mutant phage deleted in gp1 gene showed that although Gp1 is not 
essential for plaque formation, it is necessary to achieve an efficient lysis, since its absence 
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results in a decrease of the burst size. Moreover, absence of Gp1 in a M. smegmatis infection 
results in a decrease of the full form of the endolysin.  
A BLAST search using the GP1 amino acid sequence identified Gp1 homologous only in 
mycobacteriophages genomes and according to the recent analysis of mycobacteriophage 
genomes were grouped in Pham1480. Members of this gene phamily are present in the lysis 
cassette of mycobacteriophages that belong to subcluster A1, cluster E, subcluster F1 (Hatfull et 
al., 2010; Henry et al., 2010). Ms6 Gp1 showed the highest similarity to homologous proteins 
from mycobacteriophages belonging to subcluster F1. The localization of this gene family in the 
lytic cassette is highly diverse, in some cases the gene is overlapped with the predicted 
endolysin as it happens with Ms6 Gp1, in others the gene is separated from the endolysin gene 
by one intervening gene that code for putative homing endonuclease HNH motifs, while in 
some mycobacteriophages, this gene is apart from the lysin gene and distant in the genome 
(Hatfull et al., 2010). 
The gp2 (lysA), with 1152 bp, starts at a GTG codon that overlaps the gp1 TGA codon, in a 
different reading frame. gp2 or lysA was identified as encoding the endolysin protein (Garcia et 
al., 2002). A search for conserved domains showed that Ms6 LysA holds a central 
peptidoglycan recognition protein (PGRP) conserved domain (cd06583), localized between 
amino acid residues 168 and 312. PGRPs are pattern recognition receptors that bind, and in 
certain cases, hydrolyze peptidoglycan of bacterial cell walls. This family includes Zn-
dependent N-acetylmuramoyl-L-alanine amidases (EC: 3.5.1.28) which cleave the amide bond 
between N-acetylmuramoyl and L-amino acids, preferentially D-lactyl-L-Ala, in bacterial cell 
walls (Catalão et al., 2011b). Piechota et al., (unpublished work) demonstrated that LysA was 
able to cleave the bond between D-muramic acid of NGM (or NAG) and L-alanine by observing 
the release of up to 70% of the diaminopimelic acid present in purified mycobacterial cell wall, 
confirming the amidase activity of the enzyme.  
Very recently, our group identified an embebbed gene designated lys241 (referring to the number 
of amino acids of the polypeptide) in the same reading frame of lysA. Even though deletion of 
the complete lysA nucleotide sequence revealed to be essential for M. smegmatis lysis, an Ms6 
mutant lacking the longer (lysin384) or the shorter (lysin241) endolysin was shown to be viable, 
but defective in the normal timing, progression and completion of host cell lysis. In the absence 
of the longer form of LysA, lysis starts 30 min later than a wild type infection, and a reduction 
in the number of phage particles released occurs. When the smaller form (lysin241) is not 
produced, lysis starts 90 min latter than the wild type, although it does not have a significant 
effect in the number of phage particles released. These results indicate that both proteins are 
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necessary for complete and efficient lysis of M. smegmatis (Catalão et al., 2011b). Additional 
studies demonstrated that both endolysins have peptidoglycan hydrolase activity and E. coli 
crude extracts containing lysin384 or lysin241 were shown to inhibit the growth of Micrococcus 
luteus, Micrococcus pyogenes, Bacillus subtilis, Bacillus pumilus, Staphylococcus aureus, 
Mycobacterium smegmatis, Mycobacterium vaccae and Mycobacterium aurum (Catalão et al., 
2011b).  
LysA protein seems to be very well conserved among mycobacteriophages, since all 
mycobacteriophages genomes published so far encode a putative lysA-like gene and are part of 
the gene family Pham66-1. Although conserved, the LysA family appears to be highly diverse 
composed of subgenic modules with reasonably boundaries (Hatfull et al., 2010) and may 
contain amidase, glycosidase or peptidase motifs (Payne et al., 2009). The peculiar composition 
and structural features of the mycobacterial cell wall may reflect the extensive sequence 
divergence between these and other endolysins.  
gp3 (lysB), with 996 bp, starts at an ATG codon that overlaps, in a different reading frame, the 
TGA stop codon of lysA and encodes a protein of 332 amino acids. Initially it was assigned for 
this putative protein a lysin function since it showed similarity to proteins with amidase and 
endochitinase activity and also due to its localization in the lysis cassette, next to the endolysin 
gene. A BLAST search has identified homologous proteins encoded in mycobacteriophages 
genomes as well as in phages that infects Rhodococcus equi (Summer et al., 2011). These lysB-
like genes have been grouped in the gene family Pham67 (Hatful et al., 2010) and sequence 
analysis of this family showed that these proteins are highly diverse, but share the conserved 
pentapeptide motif GXSXG (Jaeger et al., 1994; Arpigny & Jaeger, 1999; Bornscheuer, 2002). 
gp4 (hol) begins with an ATG start codon located 10 nucleotides downstream of gp3 stop codon 
and encodes a 77 amino acid polypeptide. The gene product of gp4 was identified as the Ms6 
holin as it shares characteristics of class II holins, and can complement an Sλ defective mutant 
(Garcia et al., 2002). A more recent characterization of Ms6 Gp4 function, suggests that Gp4 
might function as a pinholin, since the first TMD has characteristics of a SAR domain with a 
high percentage of weakly hydrophobic or polar residues (Catalão et al., 2011a) and expression 
in E. coli of LysA and Gp4 does not result in lysis (Garcia et al., 2002). Noteworthy is the fact 
that deletion of gene gp4 in the Ms6 genome results in a viable phage but with an anticipated 
time of lysis, contrary to what is described for proteins with holin function.  
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gp5, with 372 bp, starts at an ATG codon that overlaps the hol TGA stop codon, in a different 
reading frame. Analysis of the amino acid sequence predicted a TMD at the N-terminal region 
and a very highly charged and hydrophilic C-terminal domain, showing some holin features. In 
fact, deletion of gp5 from the Ms6 genome resulted in a viable phage showing a delayed time of 
lysis, confirming that gp5 has a role in the timing of lysis. However, contrary to Gp4, Gp5 does 
not complement an Sλ defective mutant. Cross-linking experiments showed that Gp4 interacts 
with Gp5. Taking the results all together it is suggested that the combined action of Gp4 and 
Gp5 play the role of a holin. Expression of both proteins is necessary to affect a host cell lysis at 
the correct and programmed timing. Moreover, interaction of Gp5 with Gp4 may contribute to 
very precise adjustment of the timing of hole formation and to keep the infected cell productive 
allowing the assembly of more virions (Catalão et al., 2011a). 
According to the sequence similarity to putative holin genes from mycobacteriophages of 
subcluster F1, the Ms6 holin was included in the Pham95 together with gp37 from Che9d from 
subcluster F2 (Hatfull et al., 2010). Putative holin genes were also identified in 
mycobacteriophages from subcluster A2, cluster E and from cluster I, all belonging to 
Pham1981 (Hatfull et al., 2010). Whenever a holin gene has been assigned, including Ms6, it is 
closely linked to lysA. A BLAST search using Ms6 Gp5 deduced amino acid sequence 
identified a number of putative proteins with unknown functions restricted to 
mycobacteriophages with a high degree of sequence identity that have been recently grouped in 
a mycobacteriophages gene family Pham96. This gene family was identified in phages 
belonging to subcluster A2, subcluster F1, cluster I and in singleton phage Omega (Hatfull et 
al., 2010). 
Although Ms6 genome is not fully sequenced, its lytic cassette and gene organization is closely 
related to phages included in cluster F, subcluster F1, which includes phages Che8, Boomer, 
PCM, Fruitloop, Llij, Pacc40, Ramsey and Tweety (Hatfull et al., 2010).  
Of note is the fact that the lysis module of Ms6 and of the majority of mycobacteriophages, 
presents a gene (lysB) exclusive of phages infecting bacteria with similar cell wall 
(mycobacteria and rhodococcus). Its presence in the lysis module suggests that the gene product 
has a role in cell lysis. The observation of lipolytic domains in the aminoacidic sequence raises 
the possibility of an activity on the lipid contents of the mycobacteria cell envelope. 
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5. Lipolytic enzymes 
5.1. General enzyme characterization 
The term ‘lipolytic enzymes’ comprises lipases (EC 3.1.1.3), carboxylesterases (esterases, EC 
3.1.1.1) (Arpigny & Jaeger 1999; Jaeger et al., 1999; Bornscheuer, 2002) and cutinases (EC 
3.1.1.74) (Carvalho et al., 1999; Longhi & Cambillau 1999). Although the overall amino acidic 
sequence similarity of lipolytic enzymes is low, their molecular masses vary from 20 to 60 kDa, 
operating on substrates with completely different chemical or physicochemical properties. All 
lipolytic enzymes share a comparable 3D fold, showing the characteristic α/β-hydrolase fold, 
which is an eight-stranded mostly parallel α/β structure (Holmquist, 2000) and almost all belong 
to the class of serine hydrolases. The catalytic machinery of these proteins is composed by a 
nucleophile, an acid and a histidine where the active site serine is invariably located at the C-
terminal end of one of the beta strands in an extremely sharp turn towards the next helix, the 
nucleophile elbow (Egmond, 2000). The catalytic triad is composed of Ser-Asp-His (Glu 
instead of His in some lipases) and usually a consensus sequence Gly-X-Ser-X-Gly is also 
found around the active site serine (Wei et al., 1995). 
Lipolytic enzymes have attracted an enormous attention due to their potential application in 
biotechnology and because some are involved in pathogenesis of many bacteria The lipolytic 
enzymes are one of the known virulence factors in many bacteria such as Pseudomonas cepacia, 
Staphyloccocus aureus (Lonon et al., 1988; Rollof et al., 1988), and in fungal species like 
Alternaria brassicicola, Candida albicans and Fusarium graminearum (Tsuboi et al., 1996; 
Berto et al., 1999).  
5.2. Lipases vs carboxylesterases 
The two major classes of lipolytic enzymes are the lipases and the carboxylesterases. It was 
demonstrated by Sarda (1958) and Desnuelle (1961) that the fundamental difference between 
carboxylesterase and lipase activity is based on the phenomenon of “interfacial activation”, i.e., 
activity of lipases is enhanced on insoluble substrates (such as emulsions) (Rogalska et al., 
1997). Whereas carboxylesterases obey classical Michaelis-Menten kinetics, lipases need a 
minimum substrate concentration before high activity is observed. Structure elucidation 
revealed that this interfacial activation is due to a surface loop- the lid domain- that covers the 
active site, which is inaccessible to the solvent. This lid undergoes a conformational exchange 
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in a lipid-water interface, making the active site accessible, which explains the phenomenon of 
interfacial activation (Rogalska et al., 1997). Furthermore, lipases prefer water-insoluble 
substrates, typically triglycerides composed of long-chain fatty acids, whereas carboxylesterases 
preferentially hydrolyze “simple” esters, usually triglycerides bearing fatty acids shorter than 
C6. Both enzymes have been shown to be stable and active in organic solvents, but this feature is 
more pronounced with lipases (Jaeger, 1994; Arpigny & Jaeger, 1999) performed a 
classification of lipases and carboxylesterases into 8 families based on their amino acid 
sequence similarity and their conserved motifs. Despite a highly conserved tertiary fold and 
sequence similarities, lipolytic enzymes display a wide diversity of properties and of relatedness 
to other protein families (Arpigny & Jaeger 1999). 
5.3. Cutinases 
Cutinases are extracellular enzymes that have been found to occur in phytopathogenic bacteria 
and fungi (Schué et al., 2010) and catalyze the cleavage of ester bonds of cutin, resulting in the 
release of cutin monomers, polyester that protects plant leaves (Carvalho et al., 1999; 
Kolatthkudy, 2001). This family is one of the smallest members of the serine hydrolase family 
(Egmond & Vlieg 2000). In addition to the GXSXG motif, present in lipolytic enzymes, 
cutinases present the common motifs P-x-[STA]-x-[LIV]-[IVT]-x-[GS]-G-Y-S-[QL]-G and C-x 
-(3)-D-x-[iv]-c-x-G-[gst]-x(2)-[LIVM]-x(2,3)-H (www.expasy.ch/cgibin/nicedoc.pl?PDOC00 
140) (Parker et al., 2007). The most well known and most fully characterized cutinase is the 
cutinase from Fusarim solani (Longhi et al., 1999). This enzyme has been found to degrade a 
wide range of substrates, including cutin, carboxylic esters, triacylglycerols (TAGs) (Mannese 
et al., 1995), phospholipids (Parker et al., 2007) with both long and short-chain fatty acids and 
is also active in soluble substrates, such as short-chain p-nitrophenyl (pNP) esters. This 
characteristic is probably due to the fact that unlike several lipases, which require an interface, 
the catalytic site of cutinase is not covered by a lid and therefore remains accessible to the 
substrate in solution (Martinez et al., 1992). The biochemical properties of cutinases are, 
therefore, challenging the classical definition of lipases and esterases, being considered as 
intermediate between lipases and esterases (Carvalho et al., 1999; Longhi & Cambillau 1999; 
Egmond & Vlieg 2000).  
5.4. Lipolytic enzymes in mycobacteria 
Genes encoding lipolytic enzymes have also been annotated in mycobacteria genomes. 
Mycobacterium tuberculosis is a pathogen that can persist for decades in an infected host in a 
dormant state, without causing disease until the host’s immune system is weakened. Before 
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entering in this state, mycobacteria accumulate lipids, in inclusion bodies, from the host cell 
membrane degradation and form de novo synthesis. During the reactivation phase, these stored 
lipids are hydrolyzed and an active infection is established. The availability of the complete 
genome sequence of M. tuberculosis strain H37Rv (Cole et al., 1998), allowed the identification 
of 250 genes encoding proteins involved in lipid metabolism. From these, 24 genes code for 
lipolytic enzymes which were classified into a family called the “Lip Family” (LipC to LipZ). 
This classification was based on the presence of the consensus sequence GXSXG, not allowing 
the distinction between lipases and esterases. Only for LipY was experimentally determined its 
lipolytic activity (Deb et al., 2006). Genes encoding homologous proteins to cutinase of F. 
solani have also been reported to occur in various environmental mycobacterial species, such as 
Mycobacterium vanbaalenii and Mycobacterium sp. strain KMS, which have frequently been 
isolated from soils where dead plant organic matter accumulates (Belbahri et al., 2008). More 
surprisingly, similar genes have been detected in mycobacterial species that do not naturally 
encounter cutin polymers, such as human pathogens M. tuberculosis and M. bovis (Parker et al., 
2007).  
From the M. tuberculosis genome annotation, 7 cutinase-like proteins were identified, 
presenting the above cutinase motif. The presence of such enzymes suggests that they play an 
important role and that the use of host lipids for growth in vivo may be one of the major 
characteristics of the M. tuberculosis life cycle (Parker et al., 2007; Côtes et al., 2008; West el 
al., 2009). In pathogens that do not encounter cutin, the presence of these enzymes likely 
represents an evolutionary divergence, and activity on other substrates, such as the 
phospholipids, is likely to be more important (Parker et al., 2007; Côtes et al., 2008; West el al., 
2009). Lipases may not be the direct targets involved in pathogenesis but may contribute for the 
survival of the mycobacteria. It can be considered that new drugs targeting these enzymes could 
be used to alter the metabolism of the mycobacterial in order to allow a better access of the 
drugs actually available to treat the disease (Côtes et al., 2008). 
 
6. Phage therapy 
Phages were first described by Felix d’Herelle in 1917, although their antibacterial activity had 
been independently recognized by Hankin in 1896, Gamaleya in 1898 and Twort in 1915. 
D’Herelle was quick to realize the potential for therapeutic applications of phages, and he 
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championed the concept of using them to treat bacterial infections (Sulakvelidze et al., 2001). 
The potential use of phages to treat infections attracted the attention of large pharmaceutical 
companies in the United States in the 1929s and 1930s (Merril et al., 2003). For example, E. R. 
Squibb & Sons sold a phage filtrate preparation for Staphylococcus sp. Phagoid Laboratories, 
Inc., marketed an array of phage-based products, including Phagoid-Staphylococcus, Phagoid-
Gomococcus, and Phagoid-Arthritis (McKinstry & Edgar, 2005). It was not until 1940 that the 
nature of phages was clearly confirmed by electron microscopy and began the “modern” study 
of phages; however the discovery of antibiotics has diverted research attention away from phage 
therapy in the USA and elsewhere (McKinstry & Edgar, 2005), except in the former Soviet 
Union and Eastern Europe. In these countries, particularly in centres such as the Eliava Institute 
of Bacteriophages, Microbiology and Virology in Tbillisi, Georgia and the Institute of 
Immunology and Experimental Therapy in Wroclaw, Poland (Sulakvelidze & Kutner, 2005; 
Gorski et al., 2007), bacteriophages have continued to been used clinically for the treatment of 
bacterial infections continuously since 1919. The Eliava Institute has developed its 
bacteriophage collection over many decades, and producing a range of phage preparations in a 
variety of pharmaceutical forms that are able to be administered topically, orally, rectally, by 
inhalation or by injection.  
The current increasing incidence of antibiotic resistance in bacterial pathogens has justified a 
reassessment of the value of phages as antibacterial agents for medical and veterinary 
applications (Projan & Shales 2004; Norrby et al., 2005). This problem has intensified the need 
for the implementation of new effective measure to control infections by bacterial pathogens. 
Since the early 1990s the number of animal studies has expanded rapidly and prophylactic 
and/or therapeutic benefits have been reported for a range of experimental infections including 
vancomycin-resistant Enterococcus faecium (Biswas et al., 2002), P. aeruginosa (Watanabe et 
al., 2007), Mycobacterium avium (Danelishvilli et al., 2006), E. coli (Nishikawa et al., 2008) 
including Extended spectrum Beta-lactamase strains (Wang et al., 2006) among others. A high 
number of recent publication show promising success for phage therapy and human clinical 
trials with phages have been initiated by various phage companies to treat ear infections, leg 
ulcers and burn wounds (Fortuna et al., 2008).  
The application of mycobacteriophage to treat diseases has comprehensively received less 
attention. Early attempts to treat laboratory animals infected with M. bovis BCG and M. 
tuberculosis were not successful (Hauduroy & Rosset 1963; Mankiewicz & Beland 1964). 
Killing intracellular pathogens such as M. tuberculosis presents a tough challenge because in 
order to infect the target bacilli the phage need to transverse the mammalian cell membrane and 
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survive in adverse intra-cellular environments. Since phages, in contrast to antimicrobials, are 
not diffusible across membranes, strategies need to be devised to deliver the phage to the 
intracellular pathogen. A second challenge to phage therapy is the presence of granulomas 
which might prove impenetrable to the bacteriophage (Bowman et al., 1972) and thus novel 
phage delivery systems are required. A possible strategy has recently been identified where 
mycobacteriophage TM4 can be delivered by a transiently-infected nonvirulent mycobacterium 
to kill both M. tuberculosis and M. avium inside the macrophage (Ford et al., 1998; Foley-
Thomas et al., 1995). Macrophage cell lines infected with M. tuberculosis or M. avium were 
treated by the addition of M. smegmatis infected with mycobacteriophage TM4. The results 
showed that when delivered to the site where the pathogenic bacterium resides inside the 
macrophages, TM4 was effective in killing M. avium and, even more significantly, M. 
tuberculosis (Broxmeyer et al., 2002). Another study demonstrated that infected-mycobacteria 
macrophages could phagocyte mycobacteriophage D29 resulting in an effective lysis of 
intracellular mycobacteria without any deliver system (Peng et al., 2006). Phage therapy might 
be more readily applicable to less visceral mycobacterial diseases where the site of infection is 
accessible, such as in Buruli ulcer caused by M. marinum. However, no such studies have so far 
been reported. Further research is needed to overcome the existing technical barriers and enable 
the development of effective therapeutic tools (McNerney & Traoré 2005). 
Another example of the use of bacteriophages is the research into the utilization of phage lysins 
as therapeutic agents. As these enzymes break down the cell wall, they have the potential to be 
used as therapeutic agents (O’Flaherty et al., 2009). They have advantages over antibiotics in 
that they possess the host specificity of phages and so do not adversely affect normal 
microflora; there is less opportunity for resistance to emerge and they kill colonizing pathogens 
on mucosal surfaces (Fischetti, 2005). Because lysins target peptidoglycan-associated 
carbohydrates as binding epitopes, the evolution of resistance to lysins may be precluded, as 
these moieties are often essential for viability (Fischetti et al., 2006). Their major disadvantage 
is that they are unable to penetrate the outer membrane of Gram-negative cells and so their 
therapeutic activity is almost entirely directed at Gram-positive infections. Although the 
capacity of a phage endolysin to kill bacteria was first reported in 1957, it was not until 2001 
that Fischetti and co-workers demonstrated that a purified recombinant endolysin can be used as 
therapeutic agent to prevent or reduce the colonization of mucosal surfaces with group A 
streptococci in mice (Nelson et al., 2001). This strategy has been extended and proved 
potentially useful to control sepsis or other infections produced by several Gram-positive 
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bacteria, like Enterococcus feacali and E. faecium (Yoong et al., 2004), Clostridium perfringens 
(Zimmer et al., 2002) or group B streptococci (Cheng et al., 2005). This collection of successful 
reports employing phage-encoded bacterial cell wall lytic enzymes to eliminate pathogenic 
bacteria has led to the designation of these muralytic enzymes as enzybiotics (Nelson et al., 
2001).  
Mycobacteria are likely to be intractable to exogenously added endolysins, as it happens to 
Gram-negative bacteria, because of their mycolic-acid-rich outer membrane (Payne et al., 2009) 
and the complexity of the cell wall; enzymes that attack the mycobacterial envelope from the 
outside are needed as a novel therapeutic method to kill mycobacteria.  
It is increasingly clear that the future of lysin development will also focus on biotechnology and 
food biocontrol applications. One example is secretion of recombinant lysins from Lactococcus 
lactis starter cultures, used in the fermentation of milk, to combat L. monocytogenes, which can 
contaminate dairy products (Gaeng et al., 2000). Another example is the creation of transgenic 
cattle that secrete a recombinant lysin-like hydrolase, lysostaphin, into their milk to protect 
against Staphylococcus aureus mastitis (Kerr et al., 2001). 
Although the majority of reports are focused on the lysins, there are other phage components 
that may, directly or indirectly, lead to valuable new therapeutic agents. For example, the lysis 
system of certain small genome viruses, such as Qβ and φX174, encode alternative non-lysin 
lytic agents that block the enzymes responsible for early steps in bacterial peptidoglycan 
biosynthesis (Bernhardt et al., 2001b; Bugg et al., 2006). 
Despite the advantages and optimism regarding the realization of phage therapy, both past and 
present, many obstacles remain. The effective use of phages to treat infectious disease will 
require a more thorough understanding of phage-bacterium-mammal interaction in vivo. 
Pharmacokinetic models may help to predict the optimal timing of inoculation for phage therapy 
application. Growth and purification standards need to be established for any phage to be 
selected for therapeutical use. The presence of toxin genes in some phages requires the DNA 
sequencing of any therapeutic phages as part of a rigorous characterization scheme. For phage 
therapy to be effective in a clinical setting, a swift assessment of bacterial susceptibility will be 
necessary. However exploring the mechanisms by which mycobacteriophages lysis their hosts 
will certainly contribute to identify new therapeutic targets and thus to the development of 
efficient antimycobacterial agents 
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A better understanding of phage biology and phage-bacterium-host interactions and the ability 
to genetically manipulate these viruses may allow for the realization of the early promise of 
phage therapy (McKintry & Edgar 2005). 
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OBJECTIVES 
 
 
The main goal of this thesis is to study the product of lysB gene of mycobacteriophage Ms6 
lytic cassete. The presence of a conserved motif characteristic of lipolytic enzymes present in 
the aminoacidic sequence of LysB and it homologous proteins from other mycobacteriophages, 
was the basis of the research presented in this thesis.  
In order to achieve this goal it is necessary: 
• Identify and characterize lysB gene; 
• Confirm the lipolytic activity assigned to LysB due to the presence of the conserved 
motif and characterize LysB activity (substrate affinity, inhibiting substrates, active 
site); 
• Localize LysB target in the mycobacteria cell envelope; 
• Determine the importance of Lys during the infection cycle of mycobacteriophage Ms6. 
 
Due to the increasing prevalence of multi-resistant bacteria to the current antibiotics, it is 
necessary to search for different means to fight this growing problem spread throughout the 
world. Phages and phage products have been recently reevaluated as potential antibacterial 
agents for medical and veterinary applications. Our overarching goal is not only to provide 
information regarding the mechanisms involved in mycobacteriophage lysis but also to present 
new possible targets to fight one of the most important human pathogens, Mycobacterium 
tuberculosis. 
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Summary 
dsDNA bacteriophages use the dual system endolysin–holin to achieve lysis of their bacterial 
host. In addition to these two essential genes, some bacteriophages encode additional proteins 
within their lysis module. In this report, we describe the activity of a protein encoded by gene 
lysB from the mycobacteriophage Ms6. lysB is localized within the lysis cassette, between the 
endolysin gene (lysA) and the holin gene (hol). Analysis of the deduced amino acid sequence of 
LysB revealed the presence of a conserved motif (Gly-Tyr-Ser-Gln-Gly) characteristic of 
enzymes with lipolytic activity. A BLAST search within the sequences of protein databases 
revealed significant similarities to other putative proteins that are encoded by 
mycobacteriophages only, indicating that LysB and those proteins may be specific to their 
mycobacterial hosts. A screening for His6-LysB activity on esterase and lipase substrates 
confirmed the lipolytic activity. Examination of the kinetic parameters of recombinant His6-
LysB for the hydrolysis of p-nitrophenyl esters indicated that although this protein could use a 
wide range of chain length substrates (C4–C18), it presents a higher affinity for p-nitrophenyl 
esters of longer chain length (C16 and C18). Using p-nitrophenyl butyrate as a substrate, the 
enzyme showed optimal activity at 23 °C and pH 7.5–8.0. Activity was increased in the 
presence of Ca2+ and Mn2+. To the best of our knowledge, this is the first description of a protein 
with lipolytic activity encoded within a bacteriophage. 
 
 
 
 
 
 
 
 
 
 
43 
 
Chapter 2 
 
Introduction 
Bacteriophages are viruses that infect bacterial cells. For their own survival they need to infect 
sensitive bacteria, where they replicate and produce new viral particles. At the end of the lytic 
cycle, phages need to exit the bacteria, and liberate the progeny phage into the environment, and 
thus infect new bacteria. To achieve this, dsDNA phages have evolved a lytic system that 
compromises the integrity of the cell wall, resulting in bacterial lysis (Young, 1992; Young et 
al., 2000). This system consists of at least two genes: an endolysin that targets the cell wall, and 
is designed to attack one of the four major bonds in the peptidoglycan; and a holin, which 
controls the timing of lysis, and at a genetically defined time allows the endolysin to reach its 
target, leading to disruption of the cell wall, and release of the new progeny virions (Young, 
1992; Young et al., 2000; Grundling et al., 2001). In addition to these two essential genes, the 
lytic cassette of some bacteriophages may contain additional genes that may, or may not, be 
essential for lysis. The l cassette includes the Rz and Rz1 lysis genes, which encode an integral 
inner-membrane protein and an outer-membrane lipoprotein; under usual conditions these 
proteins are not essential for lysis (Young, 2005; Summer et al., 2007). Rz/Rz1 equivalents 
have been recently identified in phages of Gram-negative hosts (Summer et al., 2007); however, 
a clear function has not yet been established. In addition, dsDNA phages often encode a holin 
inhibitor or antiholin, which is a negative regulator of holins (Young, 2002). The lysis module 
of the mycobacteriophage Ms6, a temperate phage that infects Mycobacterium smegmatis 
(Portugal et al., 1989), has previously been identified, and consists of five genes (Garcia et al., 
2002). In addition to the endolysin (lysA) and the holin (hol) genes, the Ms6 lytic cassette 
comprises three additional genes whose functions have not yet been identified. Between lysA 
and hol, the gene lysB (gp3) encodes a protein of 332 aa. Analysis of the LysB deduced amino 
acid sequence has revealed the presence of a conserved pentapeptide Gly-Tyr-Ser-Gln-Gly 
motif, which matches the Gly-X-Ser-X-Gly consensus motif that is characteristic of lipolytic 
enzymes (Jaeger et al., 1994; Arpigny & Jaeger, 1999; Bornscheuer, 2002). The term ‘lipolytic 
enzymes’ comprises lipases (EC 3.1.1.3), carboxylesterases (EC 3.1.1.1) (Arpigny & Jaeger, 
1999; Jaeger et al., 1999; Bornscheuer, 2002) and cutinases (EC 3.1.1.74) (Carvalho et al., 
1999; Longhi & Cambillau, 1999). Lipases are, by definition, enzymes that have the ability to 
hydrolyse long-chain acylglycerols (≥C10), whereas esterases hydrolyse ester substrates with 
short-chain fatty acids (≤C10) (Arpigny & Jaeger, 1999; Jaeger et al., 1999; Bornscheuer, 2002). 
Cutinases hydrolyse the water-insoluble biopolyester cutin, a component of the waxy exterior 
layer of plants. In addition to cutin, cutinase substrates include a wide variety of esters ranging 
from soluble p-nitrophenyl (pNP) esters to insoluble long-chain triglycerides (Carvalho et al., 
1999; Longhi & Cambillau, 1999). Although the overall sequence similarity of lipolytic 
enzymes is low, and their molecular masses vary from 20 to 60 kDa, all these enzymes share a 
Ms6 lipolytic enzyme 
 
comparable 3D fold, which is known as the α/β hydrolase fold (Holmquist, 2000). Activity of 
these enzymes relies mainly on a catalytic triad formed by a nucleophilic Ser residue, usually 
appearing in the conserved pentapeptide Gly-X-Ser-X-Gly consensus motif, an acidic residue 
(Asp or Glu), and a His; in this order, these form the catalytic triad (Arpigny & Jaeger, 1999; 
Carvalho et al., 1999; Bornscheuer, 2002; Gupta et al., 2004). In this study, we characterize the 
gene product of lysB, and demonstrate that LysB is an enzyme with lipolytic activity. We also 
present data that show the presence of genes encoding similar proteins within the genome of 
mycobacteriophages. To the best of our knowledge, this is the first description of a lipolytic 
enzyme encoded within a bacteriophage genome, and it indicates that the lytic cassette of Ms6 
mycobacteriophage is different from the majority of the lytic cassettes described to date. The 
recombinant lipolytic enzyme was characterized with regard to optimum reaction conditions, 
substrate specificity, and effect of inhibitors and metal ions. 
 
Methods 
Bacterial strains and media 
Plasmid-transformed Escherichia coli JM109 was grown at 37 °C in Luria–Bertani (LB) broth 
or agar containing 100 µg ampicillin ml-1.  
DNA manipulation, cloning and sequence analysis.  
DNA amplification by PCR, plasmid isolation, electrophoresis and E. coli DNA transformation 
were carried out using standard techniques (Sambrook & Russell, 2001). Restriction enzymes 
and T4 DNA ligase (New England Biolabs) were used according to the supplier’s 
recommendations. In order to construct plasmid pMP302, the gene encoding lysB was PCR 
amplified with primers (restriction sites underlined) PrLys3A (59-GGGCCACTG 
GATCCCGCATCGACG-39) and PrLys3C (59-GCATGGGTCGACCTCCTATG TGCG-39), 
using Ms6 DNA as a template. The PCR product was purified with the MinElute PCR 
Purification kit (Qiagen), digested with BamHI and SalI, and cloned into the same restriction 
sites of the expression vector pQE30 (Qiagen). The resulting plasmid was transformed into E. 
coli JM109 cells. The BLAST 2.0 program at NCBI was used for similarity searches of protein 
sequences (http://www.ncbi.nlm.nih.gov/BLAST/). Sequence alignments were performed using 
CLUSTALW multiple sequence alignment software (http://www.ebi.ac.uk/clustalw/). The 
physicochemical parameters of the deduced amino acid sequence were determined by using the 
ProtParam tool at ExPASy (http://www.expasy.org). 
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Expression and purification of LysB protein.  
E. coli JM109 (pMP302) was grown in LB medium to an OD600 of 0.6, and expression of the 
recombinant His6-LysB was induced for 4 h with the addition of IPTG to a final concentration 
of 1 mM. Bacterial cells were harvested by centrifugation, washed, resuspended in 50 mM 
Tris/HCl (pH 7.5) supplemented with a cocktail of protease inhibitors (Calbiochem), and 
disrupted by passage through a French pressure cell press. Cell debris was removed by 
centrifugation, and the recombinant His6-LysB present in the supernatant was purified by 
passage through a Ni-NTA column (Qiagen), according to the manufacturer’s instructions. 
Purified protein was analysed by SDS-PAGE, followed by Coomassie blue staining and 
Western blot. The protein was detected with horseradish-peroxidase-conjugated anti-His 
monoclonal antibody (Roche). Protein concentration was determined by the Bradford method 
(Bradford, 1976), using BSA as a standard. 
Enzymic activity assays.  
The esterase and lipase activities of the purified His6-LysB were examined on LB agar plates 
containing substrates as follows: (a) 1% (v/v) tributyrin (Sigma), (b) 1% (v/v) triolein (Sigma) 
and 0.001% (w/v) rhodamine B, (c) 1% (v/v) Tween 80 with 1 mM CaCl2, or (d) 1% (v/v) 
Tween 20 with 1 mM CaCl2 (Kouker & Jaeger, 1987; Nikoleit et al., 1995). A 100 µg quantity 
of His6-LysB was spotted on the different LB media, and plates were incubated at 37 °C for 24 
and/or 48 h. Enzymic activity was indicated by the formation of a clear zone on tributyrin plates, 
by a fluorescent halo visible on irradiation with a Ultraviolet lamp on triolein plates, and by the 
formation of a white precipitate on Tween plates. For the specific detection of lipase activity, 
100 µg His6-LysB was incubated at room temperature with 100 µg 1,2-O-dilauryl-rac-glycero-
3-glutaric acid resorufin ester (Sigma) in 1 ml of 100 mM Tris/HCl pH 7.5 and 0.2% Triton X-
100. The release of resorufin was monitored by measuring the change in the absorbance at 572 
nm (ΔA572 min-1) over a period of 10 min (Schmidt et al., 2004). The hydrolase activity of 
recombinant His6-LysB was further examined on LB agar plates containing skim milk (1 %, 
w/v) or sheep blood erythrocytes (7 %, v/v). Plates were incubated at 37 °C with a spot of His6-
LysB (100 µg). 
The substrate specificity of the purified His6-LysB was measured using pNP esters (Sigma) with 
carbon chain length ranging from C4 to C18. The released pNP from the substrates p-nitrophenyl 
butyrate (pNPB; C4), p-nitrophenyl caprylate (pNPC; C8), p-nitrophenyl laurate (pNPL; C12), p-
nitrophenyl myristate (pNPM; C14), p-nitrophenyl palmitate (pNPP; C16) and p-nitrophenyl 
stearate (pNPS; C18) was monitored using a spectrophotometric assay. The enzymic reaction 
was performed at room temperature (23 °C) in a final volume of 200 µl containing 60 µg 
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purified His6-LysB ml-1, 1 mM test substrate, and 0.2% Triton X-100 in 100 mM Tris/HCl 
buffer, pH 7.5 (standard assay conditions). The released pNP was monitored at 405 nm in a 
Microplate Reader model 680 (Bio-Rad), over a period of 30 min, and quantified using a 
calibration curve of pNP (0.5–250 µM). To determine the kinetic parameters, the enzymic 
assays were performed as described above using substrate concentrations ranging from 10 µM 
to 5 µM. 
The effects of temperature and pH on the lipase activity were determined 
spectrophotometrically using pNPB (1 mM) as the substrate. The optimum temperature for 
lipase activity was determined by measuring the rate of reaction at temperatures ranging from 4 
to 63 °C, at pH 7.5. The optimum pH for His6-LysB activity was determined at room 
temperature (23 °C) using buffer containing 100 mM Tris/HCl and 0.2% Triton X-100, and 
adjusted to pH 5, 6.8, 7.5, 8, 8.8 and 9.5. 
To test the effect of metal ions on the catalytic activity of His6-LysB, the enzymic assay was 
performed at standard conditions using pNPB as the substrate, in the presence of one the 
following metal ions (5 mM): Ca2+, Mg2+, K+, Cd2+, Mn2+, Hg2+ and Zn2+. The effect of protease 
inhibitors was examined using EDTA (10 mM), PMSF (10 mM) and diethylpyrocarbonate 
(DEPC) (20 mM). The purified lipase was pre-incubated with the ions or inhibitors for 2 h at 
room temperature, and the residual lipase activity was measured. A negative control was 
performed in all experiments, using a reaction mixture of identical composition, except that 
LysB was omitted. All the assays were performed in triplicate. The kinetic parameters were 
calculated using the Sigma Plot SPSS Enzyme Kinetics module 1.1 software. One unit of 
enzyme activity was defined as the amount of enzyme that produced 1 µmol pNP min-1. 
Site-direct mutagenesis 
Site-direct mutagenesis was performed with the QuickChange II Site-Directed Mutagenesis Kit 
(Stratagene, La Jolla, CA), according to manufacture’s instructions. The plasmid pMP302 was 
used as a template for mutagenesis on the catalytic triad to change Ser168, Asp215, His246 or 
Asp306 to alanine. The oligonucleotides used are described in Table I. Introduction of the 
desired mutations was confirmed by plasmid sequencing. The mutant proteins were purified as 
described above for LysBWt. Characterization of mutated proteins activity was performed as 
described above with pNPB substrate 
 
Table 1 – Oligunucleotides used to generate point mutations in lysB  
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Name Sequence (5’ to 3’) 
PrSer168Ala Fw CACTGGCGGGATATGCGCAAGGCGCG 
PrSer168Ala Rv CGGGCCTTGCGCATATCCCGCCAGTG 
PrAsp215Ala Fw CACGTTTGGGCTGCTCACGGCGGCTCC 
PrAsp215Ala Rv GGAGCCGCCGTGAGCAGCCCAAACGTG 
PrHis246Ala Fw CGCGACTACGCCGCCCAAGGCGACCTG 
PrHis246Ala Rv CAGGTCGCCTTGGGCGGCGTAGTCGCG 
PrAsp306Ala Fw CCGGGCGATCCTCGCCGCCGGCATGTTC 
PrAsp306Ala Rv GAACATGCCGGCGGCGAGGATCGCCCGG
 
Results 
 
Cloning and expression of the lysB gene 
The DNA sequence encoding LysB was cloned into the expression vector pQE30 fused to an N-
terminal His6-tag, and the recombinant protein was expressed after induction with IPTG. 
Growth and viability of the recombinant strain E. coli JM109 (pMP302) was not affected, even 
after the addition of 2% CHCl3 (data not shown). It has been shown for other phages that 
expression of a bacteriophage lysin gene in E. coli causes cellular lysis after permeabilization of 
the plasma membrane with chloroform (Chandry et al., 1997; Henrich et al., 1995); this effect is 
also observed with the lysin LysA of mycobacteriophage Ms6 (Garcia et al., 2002). The result 
indicates that LysB is not an additional endolysin. SDS-PAGE analysis revealed the presence of 
a soluble His6-tagged LysB with a molecular mass consistent with a predicted molecular mass 
of 38.3 kDa. This was confirmed by Western blot analysis using anti-His antibody, which 
recognizes the N-terminal His6-tag on recombinant His6-LysB (Fig. 1). 
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Figure 1. (A) Western-blot of purified His6-LysB; (B) Coomassie blue-stained SDS-PAGE of purified His6-LysB. 
The sizes of the molecular mass markers are indicated on the right, and the position of the His6-LysB protein is 
indicated by an arrow. 
 
Analysis of the amino acid sequence of LysB 
A BLAST search using the Ms6 LysB deduced amino acid sequence identified a number of 
mycobacteriophage putative proteins with a high degree of sequence identity. These putative 
proteins are localized within the lysis cassette of these mycobacteriophage genomes, and, due to 
their related amino acid sequences, they have been recently grouped in a mycobacteriophage 
gene family Pham9 (Hatfull et al., 2006). The highest identity (88 %) was observed with the 
predicted amino acid sequence of Gp33 from mycobacteriophage Che8, a phage that also infects 
M. smegmatis. 
A multiple alignment of sequences with greater than 40% identity (Fig. 2) revealed the presence 
of a conserved pentapeptide Gly-Tyr-Ser-Gln-Gly motif at positions 166–170 of the LysB 
amino acid sequence; this matches the characteristic Gly-X-Ser-X-Gly motif found in lipolytic 
enzymes. An important feature of the α/β hydrolase superfamily is the presence of Asp and His 
residues, which, together with the Ser residue, form the catalytic triad (Arpigny & Jaeger, 1999; 
Holmquist, 2000; Gupta et al., 2004). LysB did not show significant amino acid sequence 
similarity with members of lipase families (data not shown); however, the alignments presented 
in Fig. 2 shows Asp and His residues conserved among the homologous proteins of the 
mycobacteriophages. Although three Asp residues (Asp215, Asp249 and Asp306) are totally 
conserved, Asp215 together with His246 might be good candidates for the catalytic triad, 
obeying the order Ser-Asp-His. Based on a comparison of the amino acid sequences, Arpigny & 
Jaeger (1999) classified bacterial lipolytic enzymes into eight families; however, LysB and the 
putative mycobacteriophage proteins do not belong to any of these families. Cutinases are not 
included in these eight bacterial lipolytic families, probably because these lipolytic enzymes 
were primarily described in fungus. Although genes coding for cutinases have been annotated in 
the genome of mycobacteria (Parker et al., 2007), LysB and the homologous 
mycobacteriophage proteins do not fit the consensus pattern of cutinases around the Ser active 
residue. From the alignment represented in Fig. 2, we can observe conserved blocks among 
these mycobacteriophage protein sequences that are not present in any of the lipases families 
described to date; therefore, we suggest that they might form a new family of lipolytic enzymes. 
No signal peptide (SignalP 3.0 server) was found, suggesting that LysB is not a secreted enzyme, 
as is the case with many lipases (Gupta et al., 2004). 
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Figure 2. CLUSTALW alignment of Ms6 LysB deduced amino acid sequence and mycobacteriophage putative LysB 
protein sequences. Mycobacteriophages: Che8 Gp33 (Q855H7), Corndog Gp70 (Q856M4), Bxz1 Gp238 (Q852W7), 
Bxb1 Gp9 (Q9B0B2), Wildcat Gp52 (Q19Y08), L5 Gp12 (Q05328) and Bxz2 Gp12 (Q857L1); the primary 
accession numbers of the UniProtKB/TrEMBL database are given in parentheses. Identical (*), highly similar (:) and 
similar (.) amino acids are indicated. Dashes represent gaps introduced by CLUSTAL to optimize the alignment. The 
conserved Asp and His residues are indicated in bold. The conserved pentapeptide is highlighted on a grey 
background. Numbers refer to the amino acid positions. 
 
Enzymic activity of LysB 
In order to determine if His6-LysB had lipolytic activity as expected, its hydrolytic capacity was 
tested using LB agar plates containing several substrates. The His6-LysB spot produced a zone 
of clearance when incubated on esterase indicator plates containing the short-chain acylglycerol 
tributyrin. A zone of a white precipitate was also observed in plates containing Tween 80 or 
Tween 20 (Fig. 3). Tween 80 and Tween 20 are esters of oleic (C18) and lauric (C12) acids, 
respectively, and can be cleaved by lipolytic enzymes to produce a fatty acid and an alcohol. 
The presence of Ca2+ causes the formation of an insoluble fatty acid salt, which was seen as a 
white precipitate. 
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On true lipase indicator plates (triolein plus rhodamine B), enzymic activity of His6-LysB was 
also observed. Rhodamine B formed a fluorescent complex with the free fatty acids released 
from the hydrolysis of lipids, and this was seen under UV light (Kouker & Jaeger, 1987). 
Fluorescence was observed after an incubation period of 24 h, and it became more intense after 
an additional 24 h incubation period (Fig. 3). This result demonstrates that His6-LysB has 
lipolytic activity on lipase substrates. No activity was observed with the LysB buffer (PBS) used 
as a negative control. Specific and sensitive detection of lipase activity can be achieved by the 
spectrophotometric detection of resorufin released from the artificial triglyceride 1,2-Odilauryl-
rac-glycero-3-glutaric acid resorufin ester (Jaeger et al. 1999; Schmidt et al., 2004).  
 
 
 
 
 
Figure 3. Effect of His6-LysB activity on agar plates containing triolein and rhodamine B, tributyrin, Tween 20 and 
CaCl2, and Tween 80 and CaCl2. The plates were incubated with 100 µg purified His6-LysB for at least 24 h at 37 °C. 
As can be observed in Fig. 4, His6-LysB was able to hydrolyse this substrate releasing resorufin 
(Fig. 4) with a ΔA572 of approximately 0.14 min-1, confirming that His6-LysB has lipase activity. 
The enzymic activity of recombinant His6-LysB was further examined on agar plates containing 
skim milk or sheep blood erythrocytes. No zones of clearance were observed following 
incubation for more than 120 h (data not shown), indicating that His6-LysB does not have 
proteolytic or haemolytic activity. 
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Figure 4. Kinetic recordings of the hydrolysis of resorufin ester by recombinant LysB at pH 7.5. The release of 
resorufin was measured by absorbance readings at 572 nm. The values shown are means from three independent 
determinations, with error bars (SD) indicated. 
 
Biochemical characterization of LysB lipase 
The activity of His6-LysB was measured using pNP esters of different chain lengths. As shown 
in Fig. 5, His6-LysB was able to hydrolyse all the tested substrates, showing the highest activity 
(0.12 U mg-1) with the short-chain pNPB (C4). In order to examine the specificity of His6-LysB 
towards the length of the acyl chain, the kinetic parameters of the enzyme were determined.  
 
 
 
 
 
 
Figure 5. Lipolytic activity of LysB towards various pNP esters (as measured spectrophotometrically). The values 
shown are means from three independent determinations, with errors bars (SD) indicated. One unit (U) of enzyme 
activity corresponds to the liberation of 1 µmol p-NP min-1. 
The rates of hydrolysis of different concentrations of all substrates were measured, and the 
substrate affinity constant (K0.5) and the turnover of the enzymic reaction (Kcat) were obtained, 
and are shown with the deduced catalytic efficiency (Kcat/K0.5) (Table II). The K0.5 values had a 
tendency to decrease with the increase in the chain length of substrates. The shortchain pNPB 
showed the highest Kcat and K0.5 values, resulting in a low catalytic efficiency (0.61 min-1 µM-1). 
Although the highest affinity was observed for the longchain pNPP and pNPS, 145 µM and 146 
µM respectively, pNPS presented a lower catalytic efficiency (0.80 min-1 µM-1) than pNPP 
(1.07 min-1 µM-1). 
Table II. Kinetic parameters of recombinant LysB for the hydrolysis of pNP esters of different chain lengths (C4–
C18) as substrates 
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The highest catalytic efficiency was observed with the relatively long-chain-length pNPL and 
pNPM, with catalytic efficiencies of 1.14 and 1.13 min-1 µM-1, respectively, indicating that 
these are the best substrates among the pNP esters examined. 
 
Effect of temperature and pH on LysB activity 
The effect of temperature and pH on the activity of His6-LysB was determined using pNPB as 
the substrate. Although a high level of residual activity (72 %) was observed in the tested 
temperature range (4–63 °C), the highest specific activity was achieved at 23 °C (Fig. 6a). The 
enzyme shows maximal activity at pH 7.5–8.8, maintaining an activity above 50% in the pH 
range 6.8–9.5. Almost no activity was observed at pH 5 (2.2 %) (Fig. 6b). 
 
 
 
 
 
 
 
 
Figure 6. Effect of temperature (A) and pH (B) on activity of His6-LysB using pNPB as the substrate. The values 
represent relative activity (%), taking the highest value of His6-LysB activity as 100 %. The values shown are 
means from three independent determinations, with errors bars (SD) indicated. 
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Effect of different metal ions and inhibitors 
The effect of different metal cations on the activity of His6-LysB was assayed using pNPB as 
the substrate. Table 2 indicates that the presence of Ca2+ or Mn2+ increased the activity of the 
recombinant protein; this was seen especially with Ca2+ (5 mM), which increased the activity by 
99.2 %. Mg2+ and K+ made no significant difference on the activity of the enzyme, while Zn2+, 
Cd2+ and Hg2+ caused a reduction in His6-LysB activity (Table 2), possibly by destabilizing the 
active conformation of the enzyme. In the presence of EDTA, no significant change in activity 
was observed, indicating that the enzyme is not a metallohydrolase. Complete inhibition was 
obtained with 10 mM PMSF, supporting the notion that a Ser residue is part of the catalytic 
triad (Table III). 
Table III. Effect of different metal ions and inhibitors on His6-LysB activity using pNPB as the substrate Metal ions 
and inhibitors were incubated with recombinant LysB in the assay buffer for 2 h at 23 °C before the assay for activity. 
 
 
 
 
 
 
The presence of DEPC at a concentration of 20 mM reduced the activity to 54% (Table 2), 
suggesting the possibility that His residues are also involved in catalysis. 
 
Ser168, Asp215 and H246 form the catalytic triad 
As stated above, the amino acids Ser168, Asp215 and His246 are good candidates for the 
catalytic triad (Fig. 2). To determine the involvement of these amino acids in the enzymic 
activity, mutant proteins were generated by changing Ser168, Asp215 or His246 to Alanine. 
Activity of the purified proteins was measured using pNPB as a substrate, as described 
previously. As expected due to the position in the Gly-X-Ser-X-Gly motif, our results confirmed 
that Ser168 is part of the catalytic triad since the catalytic efficiency of S168A was reduced to 
only 4.57% (Fig. 7). Our results also indicate that Asp215 and His246 are also part of the 
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catalytic triad, since their exchange for an Alanine resulted in a loss of catalytic efficiency of 
86.17% and 91.49%, respectively. Although Asp306 was also conserved among the aligned 
LysB proteins, the D306A mutant was still active showing a catalytic efficiency of 76.59%.  
 
Figure 7 Catalytic efficiency of wild type LysB and mutant proteins. 
 
Discussion 
In the present work, we described a gene, within the lytic cassette of the mycobacteriophage 
Ms6, encoding an enzyme with lipolytic activity. The gene lysB, which is localized downstream 
of the endolysin gene lysA, and immediately upstream of the holin gene hol, is 996 bp in length, 
and encodes a 332 aa protein (Garcia et al., 2002). The presence of the pentapeptide Gly-Tyr-
Ser-Gln-Gly within the amino acid sequence matches the consensus motif Gly-X-Ser-X-Gly 
characteristic of lipolytic enzymes, and led us to search for lipolytic activity. Since lipolytic 
enzymes include carboxylesterases and true lipases (Arpigny & Jaeger, 1999), activity of the 
recombinant protein was tested on esterase and lipase substrates. His6-LysB showed esterase 
and lipase activity on agar plates containing Tween 20, Tween 80, tributyrin or triolein. 
Definitive evidence of the lipase activity was subsequently demonstrated by the released 
resorufin from the artificial triglyceride 1,2-Odilauryl-rac-glycero-3-glutaric acid resorufin ester 
(Fig. 4). 
Lipolytic enzymes are also characterized by their ability to catalyse the hydrolysis of a wide 
range of fatty acid esters. Lipase and esterase activity may be distinguished by their substrate 
specificity using pNP esters (Bornscheuer, 2002). Although His6-LysB displayed activity 
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towards substrates with chain lengths from C4 to C18, it showed a higher affinity for pNP esters 
of longer chain length (C16 and C18). These results, together with the higher catalytic efficiency 
revealed for C12 and C14 pNP esters, indicate that the longchain substrates must represent the 
natural substrate of His6-LysB, and therefore this enzyme could be classified as a lipase. 
However the amino acid sequence of LysB does not show characteristic features of any of the 
lipase families identified by Arpigny & Jaeger (1999). Cutinases, which are also lipolytic 
enzymes, can be considered as a link between esterases and lipases because they are able to 
efficiently hydrolyse soluble esters and emulsified triacylglycerols (Mannese et al., 1995; Chen 
et al., 2007; Longhi & Cambillau, 1999; Carvalho et al., 1999). Although the LysB pentapetide 
(Gly-Tyr-Ser-Gln-Gly) is exactly the same as that in most cutinases described so far, the amino 
acid sequence around the conserved motif does not match the PROSITE 
(www.expasy.org/prosite/) pattern of cutinases. At this point, we cannot clearly classify LysB as 
a lipase or a cutinase. Although no sequence similarity was observed with any of the known 
lipases or with proteins belonging to the cutinase family, a high degree of identity was observed 
with the deduced amino acid sequences of proteins with unknown function encoded within the 
lysis cassette of mycobacteriophages infecting the non-pathogenic strain M. smegmatis or the 
pathogenic Mycobacterium tuberculosis. Alignment of these proteins showed that the 
characteristic pentapetide Gly-Tyr-Ser-Gln-Gly is very well conserved among these proteins. 
Along with this consensus motif, conserved Asp and His residues were also identified, 
suggesting that some of them may be involved in the catalytic triad. The complete inhibition of 
His6-LysB by PMSF indicated that the inhibitor might be bound to the nucleophilic Ser residue 
at the highly conserved catalytic triad, and that this Ser residue may be easily accessible to the 
substrate. This result leads us to conclude that LysB belongs to the family of serine hydrolases, 
as is the case for lipid hydrolases (Holmquist, 2000). In the presence of the His inhibitor DEPC, 
His6-LysB activity decreased 46 %, indicating that His residues participate in the active site of 
the enzyme. Inhibition by such compounds has been described for enzymes involving Ser and 
His residues in their active site (Teo et al., 2003; Nawani et al., 2006). We suggest that His246 
is the Histidine residue involved in catalysis since activity of the H246A mutant enzyme was 
reduced to 8.51%. Although three Asp residues, Asp215, Asp249 (we were not able to obtain 
this mutant) and Asp306 on LysB amino acid sequence are totally conserved. The D215A 
mutant showed a loss of activity of 86.17% indicating that Asp215 together with His246 are in 
fact the amino acids involved in the catalytic triad obeying the order Ser-Asp-His. In addition to 
these conserved residues, blocks of amino acids are also conserved among the 
mycobacteriophage putative lipolytic enzymes, and these are different from members of the 
eight lipase families described by Arpigny & Jaeger (1999). Hence, LysB and its 
mycobacteriophage putative proteins appear to be part of a novel family of lipolytic enzymes. 
His6-LysB was active over a wide temperature range, showing optimal activity at 23 °C and pH 
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7.5–8 (Fig. 6). Activity over a wide range of temperatures and pH has been described for other 
lipolytic enzymes (Kaiser et al., 2006; Teo et al., 2003). Although the optimum pH may vary 
substantially, most serine hydrolases show little or no activity below pH 5 (Schmidt et al., 2004), 
as was observed with His6-LysB. The activity of the enzyme was affected by the presence of 
metal ions. It is possible that Zn2+, Cd2+ and Hg2+ affect the catalytic site directly, since 
incubation of the recombinant His6-LysB with these cations resulted in a severe loss of activity 
(Table 2). A similar effect of these ions on the activity of microbial lipases has been observed 
by other authors (Kaiser et al., 2006; Nawani et al., 2006). Hg2+ is a thiol-reactive agent, and its 
ability to compromise His6-LysB activity suggests that thiol groups may be important for 
catalysis (Teo et al., 2003). In contrast, Ca2+ and Mn2+ exhibited a stimulatory effect on the 
enzyme activity. Ca2+ has been shown to increase the lipolytic activity of several enzymes, and 
is known to function in the structural stabilization and activation of those enzymes (Arpigny & 
Jaeger, 1999; Ma et al., 2005; Kaiser et al., 2006). Hence, we can improve the activity of the 
recombinant lipase by adding selective metal ions to the reaction system. 
The results presented in this work clearly demonstrate that LysB is a lipolytic enzyme. One can 
question what would be the role of a lipase in cell lysis. An important feature must be 
remembered: unlike other Gram-positive bacteria, mycobacteria have a complex cell wall with a 
high content of lipids (over 60 %). They possess a cell envelope structure based on long-chain 
mycolic acids esterified to an arabinogalactan polysaccharide, which is attached to the 
peptidoglycan backbone. This mycolyl–arabinogalactan–peptidoglycan complex (core) 
intercalates with an array of unusual free lipids, resulting in an effective external permeability 
barrier (Brennan, 2003; Minnikin, 1982). As happens with bacteriophages that infect Gram-
negative hosts and contain additional lysis genes, such as the genes encoding Rz and Rz1 
(Young, 2005; Summer et al., 2007), bacteriophages infecting mycobacteria may also need 
additional lysis genes. Due to the complexity of the cell wall of mycobacteria, it is easy to 
understand why a mycobacteriophage would encode a lipolytic enzyme, since one of the 
principles of phage lysis mentioned by Ry Young is that ‘the lysis process, once initiated, 
should be rapid in order to improve phage production’ (Young, 2005). 
Our overall results open the research into other cell wall hydrolases encoded by 
mycobacteriophages that target one of the most important human pathogens, M. tuberculosis, 
for which new therapeutic alternatives are urgently needed. 
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LysB targets the mycobacterial outer membrane 
 
Summary 
LysB, a mycobacteriophage Ms6-encoded protein, was previously identified as a lipolytic 
enzyme able to hydrolyse the ester bond in lipase and esterase substrates. In the present work, 
we show that LysB can hydrolyse lipids containing mycolic acids from the outer membrane of 
the mycobacterial cell wall. LysB was shown to hydrolyse the mycolic acids from the 
mycolylarabinogalactan–peptidoglycan complex where the mycolates of the inner leaflet of the 
outer membrane are covalently attached to an arabinosyl head group. In addition, treatment of 
the extractable lipids from Mycobacterium smegmatis, Mycobacterium bovis BCG and 
Mycobacterium tuberculosis H37Ra with LysB showed that trehalose 6,6’-dimycolate (TDM), a 
trehalose diester of two mycolic acid molecules, was hydrolysed by the enzyme. We have also 
determined the structures of the mycolic acid molecules that form the M. smegmatis TDM. The 
identification of a phage-encoded enzyme that targets the outer membrane of the mycobacterial 
cell wall enhances our understanding of the mechanism of mycobacteriophage lysis. 
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Introduction 
We have been undertaking bacteriophage studies with the aim of exploring their ability to 
destroy their host as a consequence of their lytic cycle. These studies are driven by either the use 
of bacteriophage itself as a therapeutic agent (phage therapy) or exploring the enzymes involved 
in cell lysis for enzyme therapy against pathogenic bacteria. At the end of their virulent cycle, 
all double-stranded DNA phages produce at least two enzymes: an endolysin, which hydrolyses 
the peptidoglycan, and a holin, a small membrane protein that defines the time of lysis and 
allows the phage endolysin to cleave its target. This leads to cell lysis and release of the progeny 
phage (Young et al., 2000; Young, 2005). Endolysins are also capable of degrading 
peptidoglycan when applied externally to the bacterial cell wall, resulting in a rapid lysis of the 
bacterial cell (Fischetti, 2005). These enzymes are normally very specific to the bacterial host of 
the phage from which they were derived (Fischetti, 2001) and this capacity renders them 
promising potential antibacterial agents. The use of purified bacteriophage lysins to destroy 
their bacterial hosts has been the subject of several recent reports (Loeffler et al., 2001; Schuch 
et al., 2002; Yoong et al., 2004; Zimmer et al., 2002). The data reported so far are all on Gram-
positive bacteria, since direct contact of endolysins with the peptidoglycan is only possible in 
such bacteria; in Gram-negative bacteria, the presence of an outer membrane prevents this direct 
interaction. In addition to endolysins and holins, some bacteriophages encode additional genes 
within their lytic cassettes. Bacteriophage lambda encodes the Rz and Rz1 proteins. These 
proteins were recently described as being involved in the fusion of the inner and outer 
membranes, which thus eliminates all the conceivable barriers to the release of the progeny 
virions (Berry et al., 2008). Genes encoding similar gene products were identified in several 
other phages infecting Gram-negative hosts (Summer et al., 2007). Thus, our present knowledge 
of the mechanism of bacteriophage lysis suggests that the complexity of phage lytic cassettes 
depends on their hosts. Hosts with a simpler envelope require the phage to possess a simple lytic 
cassette, whereas hosts with a complex envelope require the phage to have a more complex lytic 
cassette. 
In mycobacteriophage Ms6, a temperate phage that infects Mycobacterium smegmatis (Portugal 
et al., 1989), the lytic cassette comprises five genes (Garcia et al., 2002). In addition to the holin 
and the endolysin, Ms6 codes for a protein known as LysB. LysB was recently identified as a 
protein with lipolytic activity showing a higher affinity for substrates with long chain lengths 
(Gil et al., 2008). 
Despite being classified as Gram-positive bacteria, mycobacteria have a complex cell wall. This 
cell wall consists of peptidoglycan covalently linked to arabinogalactan, which is in turn 
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esterified to a variety of long chain (C60–C90), α-branched, β-hydroxy fatty acids (mycolic acids). 
This covalently linked complex, called mycolyl-arabinogalactan peptidoglycan (mAGP), is 
known as the cell wall core and forms the stable scaffolding to anchor the outer noncovalently 
associated lipids and glycolipids, including trehalose 6,6’-dimycolate (TDM or cord factor) 
(Daffé & Draper, 1998; Daffé, 2008). TDM, probably the most prominent and best-studied 
mycolic-acid-containing compound of mycobacteria, is composed of a trehalose molecule 
esterified with two mycolic acids and is implicated in the pathogenesis of certain mycobacterial 
species (Rao et al., 2005; Fujita et al., 2005). The mycolyl arabinogalactan together with TDM 
and trehalose 6’-monomycolate is responsible for the highly hydrophobic cell surface properties 
and acid-fastness of the mycobacterial cells, resulting in a resistance to dehydration and a 
natural impermeability to nutrients and antibacterial drugs (Barry et al., 1998; Crick & Brennan, 
2008, Liu et al., 1996).  
Given the complexity of the mycobacterial cell envelope, it is easy to understand why 
mycobacteriophages encode an additional lysis enzyme (LysB) that hydrolyses long chain esters 
(Gil et al., 2008). In the present work, we identify the substrates for Ms6 LysB activity in the 
cell envelope of mycobacteria. Thus, we provide evidence that Ms6 LysB targets the M. 
smegmatis outer membrane by cleaving the ester bond between mycolic acids and 
arabinogalactan in the mAGP complex and between mycolic acids and trehalose in TDM. 
Moreover, its activity is not species-specific, as Ms6 LysB could also act on the TDM from 
Mycobacterium tuberculosis H37Ra and Mycobacterium bovis BCG. 
 
Methods 
Plasmids, bacterial strains and culture media  
Plasmid pMP302, which encodes LysB, has been described previously (Gil et al., 2008). 
Escherichia coli JM109 (pMP302) was grown at 37 °C in Luria–Bertani broth or agar 
containing 100 µg ampicillin ml-1. M. smegmatis mc2155 (Snapper et al., 1990), M. bovis BCG 
(Pasteur strain ATCC 35734) and M. tuberculosis H37Ra (ATCC 25177) were grown in 
Middlebrook 7H9 (supplemented with 0.05% Tween 80, 0.2% glycerol) at 37 °C. For the 
growth of M. bovis BCG and M. tuberculosis H37Ra, the medium was also supplemented with 
10% oleic acid/albumin/dextrose/catalase enrichment (BD Biosciences). 
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Chemical and lipid standards.  
The TDM from M. tuberculosis (MTb TDM) and the trehalose standards were purchased from 
Sigma. All solvents were HPLC-grade and were purchased from Fisher Scientific. 
Expression and purification of LysB protein 
6-His-tagged LysB was expressed and purified from E. coli JM109 (pMP302) as described 
previously (Gil et al., 2008).  
Preparation of M. smegmatis cell wall components 
mAGP from M. smegmatis was obtained as described previously (Bhamidi et al., 2008). In 
addition, the purified mAGP was extracted with diethyl ether at room temperature, overnight, in 
order to remove all the free mycolic acids. The mixture was centrifuged at 2500 g for 5 min and 
the pellet was washed once more with diethyl ether. The pellet was dried under nitrogen and left 
in a chemical hood for a couple of hours.  
For total lipid extraction, the bacterial culture was centrifuged after growing for 24 h and the 
wet cell mass was extracted with chloroform/methanol [2:1, v/v, 15 ml (g wet mass)-1] at 55 °C 
overnight. The extracts were evaporated by rotary evaporation. The dried crude extract was 
stored at room temperature for further use. 
Treatment of mAGP with LysB 
Purified mAGP (1 mg) was treated with LysB (360 µg) in PBS pH 7.4, containing 0.2% Triton 
X-100 in a total volume of 400 µl. The mAGP was suspended using an ultrasonic water bath for 
1 min and the incubation was continued for 24 h at room temperature with shaking. The mycolic 
acids were extracted with 1 ml diethyl ether and washed with water. The organic and water 
layers were separated by centrifugation and the organic phase (upper layer) was collected and 
washed once with 1 ml water. After drying, the samples were analysed by liquid 
chromatographymass spectrometry (LC-MS) in negative ion mode.  
To test the effect of LysB on mycobacterium lipids, 200 µg total lipids (extracted from M. 
smegmatis, M. bovis BCG or M. tuberculosis H37Ra) were dried in a glass tube and 
resuspended in PBS buffer using an ultrasonic water bath. LysB (360 µg) was added and the 
samples were incubated at 37 °C for 24 h. After treatment, chloroform and methanol were added 
to the samples such that the ratio was 8:4:3 (chloroform/methanol/water); the organic layer was 
then transferred to a new tube and dried. For analysis, total lipids were redissolved in 
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chloroform to 10 mg ml-1 and then separated by 1D thin-layer chromatography (TLC) on 
aluminium-backed silica 60 F254 gel plates (EMD Chemicals) developed with 
chloroform/methanol/water (20:4:0.5; by volume) and visualized with 10% CuSO4 in 8% H3PO4 
followed by charring at 200 °C. In parallel, control assays were performed in the same 
conditions using PBS instead of the Ms6 LysB protein.  
Separation and purification of the lipid hydrolysed from M. smegmatis by LysB (Msmeg_1) 
The crude lipid extract (20 mg) was applied to a Silica Gel 60 (Merck, 70–230 mesh) column (2 
x 50 cm) and eluted successively with chloroform (4 x 100 ml), acetone (4 x 100 ml) and 
methanol (4 x 100 ml). Fractions of 100 ml were collected, dried and monitored for Msmeg_1 
by TLC. 
Determination of Msmeg_1 structure 
Purified Msmeg_1 was analysed for the presence of mycolic acids as described by Phetsuksiri et 
al. (1999). Briefly, the lipid was resuspended in 2 ml of 15% tetrabutylammonium hydroxide 
(TBAH; Sigma) and saponified at 100 °C overnight. After cooling, 2 ml water, 3 ml 
dichloromethane and 300 µl iodomethane (Aldrich) were added to the entire reaction mixture, 
which was then left on a shaking platform for 4 h. After centrifugation, the upper layer was 
discarded and the lower organic phase was washed three times with 3 ml water. The washed 
lower phase was dried by nitrogen flow, extracted with 4 ml diethyl ether, sonicated for 5 min 
and centrifuged at 2500 g. The ether extract was transferred into new glass tubes and dried. The 
mycolic acid methyl esters (MAMEs) from intact M. smegmatis were obtained in a similar 
fashion, starting with whole cells. MAMEs derived from Msmeg_1 and from M. smegmatis 
were fully separated into subclasses by threefold TLC developed with n-hexane/ethyl acetate 
(95:5; volume/volume) and then silica scrapings were extracted in diethyl ether overnight. The 
ether extracts were washed with water, dried and analysed by LC-MS. The mycolic acid methyl 
esters were visualized with 10% CuSO4 in 8% H3PO4 spray followed by charring at 200 °C for 
analytical purposes. 
In order to determine the sugar composition of Msmeg_1, alkaline hydrolysis was performed on 
TDM standard and pure Msmeg_1 (10 μg of each sample) by adding 1 ml of 1 M 
KOH/methanol for 2 h at 80 °C. Extracts were cooled to room temperature and neutralized with 
glacial acetic acid. The sugars were extracted with chloroform/water (1:1, v/v) and the aqueous 
layer containing the sugars was dried under nitrogen flow. The samples together with the 
trehalose standard (1 μg), to which was added pyridine, were acetylated with 100 μl of acetic 
anhydride (Sigma) at 120 °C for 1 h. The extracts were cooled at room temperature and 
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extracted with chloroform/water (1:1, v/v). The resulting acetylated products were analyzed by 
GC-MS with Varian CP-3800 Gas Chromatograph (Varian, CA, USA), using a FactorFour 
Capillary Column (VF-5ms, 30m x 0.25mm, 0.25 μm I.D., Varian). GC oven was operated at 
50 °C for 1 min, and then the temperature was increased to 150 °C at a rate of 30 °C/min. From 
4.33min to 36.8min, the temperature was increased to 330 °C at a rate of 8 °C/min. The 
retention times and mass spectra were compared with those of trehalose standard. 
LC-MS assay 
LC-MS was performed on an Agilent 6220 high resolution time of flight mass spectrometer 
equipped with a MultiMode source selected to be in the dual atmospheric pressure chemical 
ionization/electrospray ionization mode. The HPLC is equipped with an Agilent 1200 binary 
pump. In LC-MS experiments, a Waters XBridge (C18, 2.1 x 150 mm) with 5 µM particle size 
was used. For analysis of free mycolates (negative mode), mycolate esters (positive mode) and 
intact TDM (positive mode), the same HPLC conditions were used. The column temperature 
was 45 °C. The separation was done using a gradient of solvent A (99% methanol, 1% 500 mM 
ammonium acetate) and solvent B (79% n-propanol, 20% hexane, 1% 500 mM ammonium 
acetate) from 100% A to 100% B at a flow rate of 0.32 ml min-1 over a period of 45 min. The 
drying gas temperature was 300 °C and the vaporizer temperature was set at 200 °C. Typically, 
5 µl of a 1 mg ml-1 sample was injected for analysis. The mass spectrum was acquired from m/z 
250 to 3200 Da with a frequency of one scan per second. The resulting data were analysed by 
using Agilent’s Mass Hunter program. 
 
Results and Discussion 
 
LysB hydrolyses the mAGP complex 
In order to evaluate the ability of LysB to act on mAGP, this complex was obtained from M. 
smegmatis and incubated with LysB for 24 h. Released mycolic acids were extracted and 
analysed by LC-MS (negative ion mode). As shown in Fig. 1, free mycolic acids were observed 
in samples treated with LysB, while in the control sample (where LysB is absent) no mycolic 
acids were detected. The dominant mycolic acids were those expected from M. smegmatis – α- 
and α’-mycolates – which contain no oxygen beyond the hydroxyl group in the meromycolate 
moiety, as well as epoxy mycolates containing additional oxygen in the meromycolate moiety 
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(Barry et al., 1998; Marrakchi et al., 2008). Since, in the mAGP complex, the non-reducing 
termini pentaarabinosyl motifs in the arabinogalactan are esterified to mycolic acids, the 
observation of the release of mycolic residues demonstrates that LysB acts on this bond and thus 
disrupts the inner leaflet of the mycobacterial outer membrane (Hoffmann et al., 2008; Zuber et 
al., 2008). This result is consistent with the esterase activity of Ms6 LysB, previously reported 
by our group (Gil et al., 2008), and with the report of a mycolyl arabinogalactan esterase 
activity for the homologous LysB found in mycobacteriophage D29 (Payne et al., 2009). 
 
 
 
 
 
 
 
 
 
 
Figure 1. LC-MS (negative ion mode) identification of mycolic acids released from mAGP after LysB treatment. (a) 
Total ion chromatograms from non-treated and treated (LysB) mAGP samples. (b) The negative ion mass spectra 
(averaged from 19 to 25 min) of non-treated and treated mAGP samples from m/z 920 to 1232. The mAGP sample 
treated with LysB showed the presence of several peaks, identified as mycolic acids. α, α-mycolates; α’, α’-
mycolates; e, epoxy mycolates. The ion at m/z 980 corresponds to a calibration reference compound. 
Despite the fact that these homologous proteins share a low identity with the amino acid 
sequence, they have in common the conserved motif GXSXG of lipolytic enzymes (Gil et al., 
2008, Hatfull et al., 2006). This suggests a common function and thus a common substrate for 
them. The esterase activity against the mycobacterial outer membrane is parallel to the lambda 
Rz/Rz1 homologues of Gram-negative bacteria, which, as proposed by Berry et al. (2008), 
mediate the final step of host lysis by fusing the inner and outer membranes. Although different 
from a Gram-negative outer membrane, the existence of an outer membrane layer in the 
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mycobacterial envelope has long been postulated (Minnikin, 1982). Despite the fact that its 
arrangement is still under debate, recent work has clearly shown its existence (Hoffmann et al., 
2008; Zuber et al., 2008). The existence of additional lysis genes in mycobacteriophage 
genomes, coding for proteins able to break the outer membrane linkage to the cell wall skeleton, 
enables the mycobacterial phage to efficiently escape from their lysed host. 
 
LysB hydrolyses lipids from the extractable lipid fraction 
Taking into account that LysB has a broad range of lipolytic activity (Gil et al., 2008), we 
decided to investigate its ability to hydrolyse other cell envelope lipids. Total extractable lipids 
from M. smegmatis were extracted and treated with LysB. TLC analysis revealed that the lipid 
profile changes after LysB treatment (Fig. 2, lanes 1 and 2). One of the major lipids disappears 
from the LysB-treated sample. Interestingly the same result is observed with total lipids from M. 
tuberculosis H37Ra (Fig. 2, lanes 4 and 5) and M. bovis BCG (data not shown). This indicates 
that LysB is not specific for M. smegmatis, as it is able to hydrolyse lipids from other 
mycobacterial species. The lipid hydrolysed from M. smegmatis by LysB was designated 
Msmeg_1. Its RF value was very similar to that of the Mycobacterium tuberculosis (MTb) TDM 
(Fig. 2, lane 3), suggesting that it could be the M. smegmatis version of TDM. The long acyl 
chains of the mycolic acid residues differ in structure and chain length within TDM and thus, 
TDMs from different mycobacteria have slightly different RF values (Fujita et al., 2005). 
 
 
 
 
 
 
 
Figure 2. Thin layer chromatogram developed with chloroform/methanol/water (20: 4:0.5 by vol.) of total lipid 
extract from M. smegmatis (lane 1), total lipid extract from M. smegmatis treated with LysB (2), Mtb TDM standard 
(3), total lipid extract from M. tuberculosis H37Ra (4) and total lipid extract from M. tuberculosis H37Ra treated with 
LysB (5). 
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Msmeg_1 is the M. smegmatis trehalose dimycolate 
To investigate the composition of Msmeg_1, we produced a large amount of M. smegmatis cell 
mass, extracted Msmeg_1 and purified it by silica gel chromatography. To search for the 
presence of mycolic acids, Msmeg_1 was de-esterified with TBAH and concomitantly, the 
released fatty acids were methyl esterified with methyl iodide and then analysed by using TLC. 
After a threefold development with n-hexane/ethyl acetate (95:5, v/v), we observed three groups 
of MAMEs from both Msmeg_1 and intact M. smegmatis (Fig. 3a). The three spots observed 
correspond to α-, α’- and epoxy mycolates. The different types of MAMEs were eluted from the 
TLC and analysed by LC-MS. This analysis revealed the presence of M + Na ions with m/z 
values ranging from 951 to 1274, and the major components were identified as shown in Fig. 
3(b). This result demonstrates that Msmeg_1 has mycolic acids in its structure. The pseudo-
molecular ions obtained show a mass increase of 38 amu compared with those in Fig. 1. This 
corresponds to the mycolic acids being analysed as methyl esters and thus detected as sodiated 
methyl esters (positive mode) rather than as non-esterified carboxylate anions (negative mode). 
In addition, after separation into the mycolate classes, more details can be seen than are 
apparent in Fig. 1, namely the epoxy mycolates range from 74 to 84 carbon atoms, the α’-
mycolates range from 62 to 66 carbon atoms and the α-mycolates range from 74 to 82 carbon 
atoms. As is the case for the free mycolates (Fig. 1), the exact mass values for components 
identified as epoxy mycolates are all consistent with the additional oxygen atom in the molecule.  
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Figure 3. Analysis of MAMEs by TLC and MS. (a) TLC fractionation of MAMEs into subclasses: thin-layer 
chromatogram of MAMEs from whole M. smegmatis (lane 1) and Msmeg_1 (lane 2). The development solvent was 
n-hexane/ethyl acetate (95:5, v/v), used three times. α , α -mycolates; α‘, α’-mycolates; e, epoxy mycolates. (b) LC-
MS analyses of MAME subclasses extracted from Msmeg_1, carried out in positive ion mode. Top, α-mycolates; 
middle, α’-mycolates; bottom, epoxy mycolates. The presence or absence of peaks marked with an asterisk (*) was 
variable and, based on their masses, was probably due to oxidation reactions occurring on the silica gel. 
TDM is composed of mycolic acids and a trehalose disaccharide; to confirm the presence of the 
sugar molecule, we performed alkaline hydrolysis on Msmeg_1. The sugar was extracted and 
acetylated, and the resulting products were analysed by gas chromatography-MS. In parallel, 
two standards (MTb TDM and trehalose) were treated exactly as Msmeg_1 sample. Our results 
showed that the retention time and mass spectra (Fig. 4) obtained for Msmeg_1 and for the MTb 
TDM standard were the same as the trehalose standard, clearly demonstrating that the sugar in 
Msmeg_1 is the trehalose. Taken as a whole, the results clearly show that Msmeg_1 is in fact M. 
smegmatis TDM. 
 
 
 
 
 
 
 
 
Figure 4. Identification of trehalose in Msmeg_1 and MTb TDM standard by GC-MS.. 
 
Treatment of purified Msmeg_1 with LysB 
When we analysed pure Msmeg_1, treated and non-treated with LysB, in the positive ion mode 
by LC-MS, the M + Na pseudo-molecular ions in the region from m/z 2160 to 2700 showed the 
presence of several peak clusters for the non-treated Msmeg_1, while no such ions were 
observed for the treated sample (Fig. 5). This result is in accordance with our previous TLC 
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results, in which LysB was able to hydrolyse Msmeg_1. LC-MS analysis (negative mode) for 
free mycolate in the same samples showed the presence of the expected mycolates in the LysB-
treated sample but not in the untreated sample (Fig. 6). These analyses directly showed the 
action of LysB on Msmeg_1. The mass spectrum of the intact Msmeg_1 (Fig. 5) shows 
abundant M + Na ions in three clusters with the dominant m/z values of 2187, 2395 and 2603 
(fully 12C isotope mass). These correspond to the combinations of α’/α’, α’/α, and a mixture of 
α/α and α/epoxy mycolates esterified to trehalose. In Table 1, the most probable combination of 
mycolic acids present in each molecular species was determined based on the weights of 
mycolyl residues known to be present from our mycolate analysis (Figs. 3 and 6). Similar 
heterogeneity in intact TDM molecules from other mycobacterial species has been found 
previously (Fujita et al., 2005).  
Thus, TDM from M. smegmatis has now been shown to be a substrate for LysB. In addition, 
structural details beyond the early initial characterization of TDM in M. smegmatis (Mompon et 
al., 1978) have been obtained. These include the composition of the mycolic acid components 
(especially the epoxy mycolates) and the determination of which pairs of mycolates are 
combined on the trehalose disaccharide (Table 1). 
 
 
 
 
 
 
 
 
Figure 5. LC-MS analysis (positive ion mode) of purified Msmeg_1 treated with LysB and non-LysB-treated 
enzyme-treated Msmeg_1. The non-treated Msmeg_1 spectrum revealed the presence of several ion clusters between 
m/z 2158 and 2647. 
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Treatment of intact M. smegmatis with LysB 
Enzymes that attack the mycobacterial cell envelope from the outside are needed as a novel 
therapeutic method to kill mycobacteria. Such enzymes can also be used as reagents to gain 
access to the contents of the mycobacterial cell for DNA and RNA analysis, and also for 
immunohistochemical analysis. Currently, lysozyme has some efficacy for the non-therapeutic 
purposes but is not as efficient as would be desired and must be used at very high concentrations. 
Its lack of robust activity makes it an impractical reagent to develop on its own for therapeutic 
purposes. Although the relatively high molecular mass of LysB (predicted molecular mass of 
38.3 kDa) raised the concern that it would not be able to gain access to the mycolate bonds, we 
did test its ability to inhibit the growth of M. smegmatis. 
 
 
 
 
 
 
 
 
 
Fig. 6. LC-MS (negative mode) identification of mycolic acids from released Msmeg_1 after LysB treatment (top 
panel). The bottom panel is a control with no LysB treatment. The mycolates, thus identified, were consistent with 
the more detailed analysis of TDM shown in Fig. 3.α, α-mycolates; α’, α’-mycolates; e, epoxy mycolates. The ion at 
m/z 980 is from the calibration standard; the ions at m/z 955, 996 and 1024 (found in both the control and the sample) 
are of unknown origin, and can also be seen in Fig. 1. 
We found that, in the presence, but not in the absence, of Tween 80, LysB effectively killed M. 
smegmatis. Further investigation revealed that this was probably not due to the detergent itself 
but due to the toxicity of oleic acid released from the Tween 80 by LysB (F. Gil, unpublished 
observation). Therefore, although we have demonstrated that LysB is able to hydrolyse the 
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mycolate–arabinogalactan bond and the mycolate–trehalose bond when Ms6 LysB is added 
from the outside, it is unable to disrupt the outer membrane sufficiently to kill the mycobacteria. 
 
Conclusions 
In the present work, we demonstrate that the mycobacteriophage Ms6 LysB lipolytic enzyme is 
able to hydrolyse ester bonds that are necessary for the integrity of the mycobacterial envelope. 
In particular, the arabinosyl head groups of the inner leaflet of the outer membrane (ultimately 
attaching the inner leaflet to peptidoglycan) are cleaved from the mycolates. Importantly, TDM 
is also de-esterified by the enzyme and, although the exact location of TDM in the cell envelope 
in not precisely defined, it is likely to be present in the outer leaflet of the outer membrane. It 
should be noted that the gene encoding LysB is localized in the lytic cassette of Ms6, 
downstream of the endolysin gene, supporting a role in mycobacterial lysis (Garcia et al., 2002). 
Thus, we propose that LysB activity, together with LysA acting on the peptidoglycan 
(unpublished data), results in a more efficient breakage of the cell wall, allowing a robust 
dissemination of the new phage particles. This is in agreement with a report (Payne et al., 2009) 
in which a deletion of lysB in the mycobacteriophage Giles genome results in a reduction of the 
mycobacteriophage plaque size, indicating that Giles LysB, although not essential for plaque 
formation, is required for efficient phage release. Unfortunately, LysB is unable to hinder the 
growth of M. smegmatis when added to growing cultures. 
Table 1. The most probable combination of mycolic acids present in TDM of different molecular masses isolated 
from M. smegmatis 
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*The C number refers to the number of carbons in the mycolate chains (does not include the 12 carbons 
of trehalose). The D number indicates the total number of double bonds. †, α-mycolates; α’, α’-mycolates; 
e, epoxy mycolates. 
Of note is the fact that LysB hydrolyses the M. smegmatis TDM, a glycolipid present in the lipid 
outer layer of mycobacteria, which has been associated with virulence in pathogenic bacteria. 
Our results suggest that TDM from the slow-growing mycobacteria are also hydrolysed by 
LysB, indicating that homologous proteins from other mycobacteriophages will also hydrolyse 
this glycolipid. It has already been shown that mycobacteria can survive after removal of the 
TDM, but viability of these bacteria inside macrophages is significantly reduced (Indrigo et al., 
2002). 
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Summary 
All dsDNA phages encode two proteins involved in host lysis, an endolysin and a holin. In 
addition, some bacteriophages encode additional proteins like the Rz and Rz1 present only in 
bacteriophages that infect Gram-negative bacteria. Recently it was identified in 
mycobacteriophages a gene located in the lytic cassette, encoding a protein with mycolyl 
arabinogalactan esterase activity. Taking in consideration the bacterial complex cell wall that 
mycobacteriophages encounter during their life cycle it is interesting to evaluate the role of 
these proteins in lysis. In the present work we used a novel recombineering technique, BRED, 
that allowed us to engineer an Ms6 mycobacteriophage defective on lysB gene and an Ms6 
mycobacteriophage producing a LysB protein with a His6-tag. It was determined that LysB 
production begins 120 minutes post infection. Ms6ΔlysB was able to form plaques indicating that 
lysB gene is not essential for Ms6 viability. Comparison between Ms6ΔlysB and Ms6Wt showed no 
differences in the plaque size with both phages having a similar lysis kinetic. Moreover, the 
burst sizes are also similar. Ms6 lysB defective showed that although it is not observed a delay 
of lysis when compared with the Ms6 wild type, it takes more time to accomplish a full host 
lysis. 
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Introduction 
Double stranded DNA phages must lyse their hosts in order to guarantee their own survival in 
the biosphere. The main barrier to the release of the new phage particles at the end of a lytic 
cycle is the bacterial cell wall and thus, compromising this barrier is the main goal for the lytic 
process. To achieve lysis, phages need to synthesize at least two essential proteins: an 
endolysin, a protein designed to attack at least one of the three types of the covalent bonds in the 
peptidoglycan; and a holin, a small protein that accumulate in the cytoplasmic membrane and a 
have a role in the timing of lysis (Young, 1992; Young et al., 2000; Gründling et al., 2001). 
Some holins form pores large enough to allow the passage of endolysins that have accumulated 
in the cytoplasm. This is the case of one of the most well studied bacteriophage, the phage λ 
(Young, 1992). In other cases, endolysins are endowed with signal sequences that, with the 
participation of the host sec-system are translocated to the cytoplasmic membrane to be 
positioned in the periplasm. Examples are the endolysins of phage phages P1 and the lambdoide 
phage 21, which carry an N-terminal signal arrest release (Wang et al., 2000; Young et al., 
2000; Xu et al., 2004; Xu et al., 2005) and Lys44, the endolysin of the Oenococcus phage 
fOg44, which carries a typical cleavable signal peptide (São José et al., 2000). In these 
examples, although the holin is not required for endolysin export, its role in lysis is still 
essential to define the timing of lysis.  
In addition to these essential genes, most phages infecting Gram-negative bacteria contain 
additional genes whose products are involved in disrupting the outer membrane. One of the 
most well studied are the λ Rz and Rz1 genes (Young, 2006). Rz encodes a class II inter 
membrane protein with a periplasmic C-terminus. The Rz1 coding region is embedded out of 
frame within the Rz gene and encodes an outer membrane lipoprotein with the lipolyl moieties 
inserted in the inner leaflet of the outer membrane. It was proposed that these two proteins 
interact by virtue of their C-terminus, forming a complex that spans the entire periplasm, 
providing a physical link between the inner and outer membrane. This would cause the 
cytoplasm and the environment to become topologically equivalent and, thus all conceivable 
barriers to the release of the progeny virions would be eliminated (Berry et al., 2008). In 
addition to λ, Rz/Rz1 homologues were also described in other phages infecting Gram-negative 
bacteria (Summer et al., 2007). In the study performed by Summer et al. (2007), functional 
homologous of Rz/Rz1 encoded by a single gene were also identified in some phages; these new 
class of proteins, named spanins, are functionally equivalent to the Rz/Rz1 proteins.  
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Taking in to consideration that Gram-negative bacteria possess an external membrane, one can 
understand why bacteriophages that infect these bacteria would have the necessity to encode 
additional genes with the purpose of achieving a more efficient lysis. The process of host lysis 
in λ was suggested to comprise three steps that compromise the inner membrane (IN), the 
peptidoglycan (PG) layer, and the outer membrane (OM), reflecting the order of genes involved 
(Berry et al., 2008). The first step would comprehend the holin harmless accumulation in the IM 
followed by sudden formation of extremely large and irregular holes. Besides terminating with 
macromolecular synthesis and virion assembly, this step would allow the phage endolysin to 
gain access to the peptidoglycan and its degradation, accomplishing step two. PG destruction is 
followed by a third step that involves disruption of the outer membrane, which requires Rz and 
Rz1 action. The same thoughts could cross our minds when we think in the lytic cassettes of 
phages that infect mycobacteria that also possess an outer membrane, with LysB-like proteins 
might having a similar role to Rz and Rz1 proteins. Although mycobacteria are classified as 
Gram-positive bacteria they are unusual in possessing a mycolic acid-rich outer membrane that 
is covalently attached to an arabinogalactan-peptidoglycan complex (Daffé, 2008). Our group 
has been focused in studying the lysis mechanism of mycobacteriophage Ms6, a Siphoviridae 
phage that infects Mycobacterium smegmatis. The Ms6 lytic cassette encodes five proteins 
(Garcia et al., 2002). In addition to the holin and the endolysin, Ms6 codes for: (i) a chaperone 
(Gp1) that was demonstrated to interact with the N-terminal sequence (60 amino acids) of the 
Ms6 endolysin, its effector (Catalão et al., 2010); (ii) an additional lysis protein, LysB, recently 
identified as a lipolytic protein, that specifically targets the lipid layer of the mycobacterium 
complex cell wall (Gil et al., 2008; Gil et al., 2010), cleaving the mycolyl arabinogalactan bond 
to release free mycolic acids (Payne et al., 2009, Gil et al., 2010); (iii) and another protein with 
some holin features (Gp5) which was suggested that combined with Gp4 would play the role of 
a holin, since expression of both proteins is necessary to effect lyse the host at the correct and 
programmed timing (Catalão et al., 2011a). 
LysB homologous proteins were identified in mycobacteriophages genomes as well as in phages 
that infect Rhodococcus equi (Summer et al., 2011). From the 81 compared mycobacterial 
genome sequences, 77 encode a LysB-like protein (Hatfull et al., 2010, Henry et al., 2010). 
In the present work we investigated the LysB role on the Ms6 lytic cycle through the analysis of 
the biological parameters of a Mycobacterium smegmatis infection with an Ms6 derivative 
mutant deleted in lysB gene. 
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Materials and Methods 
Bacterial strains, phages, plasmids and culture conditions 
Bacterial strains, phages, plasmids and oligonucleotides used throughout this study are listed in 
Table 1. M. smegmatis strains were grown at 37 °C in 7H9 medium (BDBiosciences) with 
shaking or Middlebrook 7H10 (BDBiosciences), supplemented with glucose and CaCl2.  
Table 1. Strains, bacteriophages and plasmids used in this study 
Strains, plasmids, 
bacteriophages or 
oligonucleotides 
Description Source or reference 
Bacteria   
     Mycobacterium smegmatis  
      mc2155 
High-transformation-efficiency mutant of  
M.smegmatis ATCC 607 
Snapper et al. (1990) 
Bacteriophages   
         Ms6Wt Temperate bacteriophage from M. smegmatis Portugal et al. (1989) 
         Ms6ΔlysB 996 bp in-frame deletion of the Ms6 lysB gene This study 
         Ms6lysBHis6Tag His6Tag insertion at the 3’ end of the Ms6 lysB gene This study 
Plasmid   
         pJV53 Derivative of pLAM12 with Che9c 60 and 61 under 
control of the acetamidase promoter; Kanr 
Van Kessel, J. C. & 
Hatfull, G. (2007) 
Oligonucleotides Sequence 5’-3’  
         PrΔlysB CTCGGCGGAAAAACCCTCCTCGTGGACGCG 
GTAGCAGAACTGTTGGGCCACTGATAGGAG 
GCACCCATGCTGACACGTTCATTCTGGATCG 
ACGCCGCCGAGCG 
Ms6 lysB 996 bpΔ 
 
         PrExtΔlysBFw CGAGATCCTGCGGCAACTGCGCGGATACAA 
CCTCACTGGCTGGCCGCAGCTCGGCGGAAA 
AACCCTCGTGGACG 
Extend Pr∆lysB 
 
         PrExtΔlysBRv CCCCGGCGCCGAGGGTGGCGATCGCGGTTT 
GGGCGAATGTGCGTATGGCACGCTCGGCGG 
CGTCGATCCAGAATG 
Extend Pr∆lysB 
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         DADA ΔlysB-PCR GCGCTAGCAGAACTGTTGGGCCACTGATAG Ms6ΔlysB 
         DADA Ms6-PCR CGTCTCGTACTGCACGTACCGGTTCTTC Ms6ΔlysB;  
Ms6lysBHis6 
         PrlysBHis6Tag CTACAACCCCCAGCCCGCCATCGACTACCT 
ACGCACACACCACCACCACCACCACTGAG 
AGGCACCCATGCTGACACGTTCATTCTGG 
ATCG 
Ms6 lysBHis6Tag 
insertion 
 
         PrExtlysBHis6Fw CTCGACGCCGGCATGTTCTTCGCGAAACGC 
ACCGGCCCGCACGTGGACTACAACCCCCAG 
CCCGCCATCGACTAC 
ExtendPrlysBHis6Tag 
         PrExtlysBHis6Rv GTGGCGATCGCGGTTTGGGCGAATGTGCGT 
ATGGCACGCTCGGCGGCGTCGATCCAGAAT 
GAACGTGTCAGCAT 
ExtendPrlysBHis6Tag 
         DADA lysBHis6-PCR CCTACGCACACACCACCACCACCAC Ms6 lysBHis6Tag 
Ms6 bacteriophage amplification and harvesting 
A standard plaque assay was performed and the plates were used to harvest phage. High-titre 
phage suspension was obtained by adding 5 ml of SM buffer (10 mM Tris-HCl; pH 7.5; 10 mM 
MgSO4; 68.5 mM NaCl; 1 mM CaCl2) to a plate from a plaque assay for an overnight 
incubation at 4 °C. The buffer was then removed, centrifuged (1000 g for 10 min) and the 
supernatant was filtered through a 0.2-µm filter. The approximate phage titre of the suspension 
was subsequently evaluated using a serial dilution method. 
Construction of Ms6 mutant phages  
Construction of Ms6 mutant phages was performed using Bacteriophage Recombineering of 
Electroporated DNA (BRED) in M. smegmatis. Recombineering substrates and BRED strategy 
were done as described previously (Marinelli et al., 2008; Catalão et al., 2010). Briefly, for 
deletion of the Ms6 lysB, a 100 bp oligonucleotide, Pr∆lysB, that has 50 bp of homology 
upstream and downstream of the region to be deleted was extended by PCR using two 75 bp 
extender primers, PrExt∆lysBFw/ PrExt∆lysBRv, which have 25 bp of homology to the ends of 
the 100-mer and add an additional 50 bp of homology on either end. For the His6-tag insertion a 
92 bp oligonucleotide (PrlysBHis6tag) was extended with primers PrExtlysBHis6Fw/ 
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PrExtlysBHis6Rv. The final 200 bp dsDNA products were purified using MinElute PCR 
Purification Kit (QIAGEN) and co-electroporated with Ms6Wt DNA into electrocompetent 
recombineering cells of M. smegmatis mc2155:pJV53. Cells were resuspended in 7H9 
supplemented with 0.5% glucose and 1 mM of CaCl2, incubated at 37 °C for 2 h (prior to lysis) 
and plated as top agar lawns with M. smegmatis mc2155. Phage plaques were picked into 100 µl 
SM buffer, eluted for two hours at room temperature and analysed by Deletion Amplification 
Detection Assay (DADA)-PCR (Marinelli et al., 2008) with primers DADA ΔlysB-PCR/ 
DADA Ms6-PCR to detect lysB deletion or with primers DADA lysBHis6-PCR/ DADA Ms6-
PCR. Mixed primary plaques containing both the mutant (either lysB deletion or His6Tag 
insertion) and the wild type DNA were eluted as described above, and serial dilutions were 
plated with M. smegmatis. Individual secondary plaques or lysates were screened by DADA-
PCR for the presence of pure lysB deletion or lysB His6 Tag insertion mutant phages. 
LysB expression in M. smegmatis-infected cells 
Examination of LysB synthesis in M. smegmatis was performed as previously described (São-
José et al., 2000; Catalão et al., 2010). An exponential growing culture of M. smegmatis mc2155 
was infected with Ms6LysBHis6 at an approximate multiplicity of infection (m.o.i) of 10 and 
incubated for 30 minutes at 37 °C for phage adsorption. 10 ml samples were withdrawn at 30 
min intervals for 240 min, cells were pellet by centrifugation and frozen at -20 °C. After 
thawing, cells were concentrated 100-fold in phosphate buffer saline (PBS) supplemented with 
20 mg of lysozyme per ml. After an incubation period at 37 °C for 1 h, 25 μl of 5× SDS-PAGE 
sample buffer were added followed by incubation at 100 °C for 5 min to complete cell lysis. M. 
smegmatis extracts were analysed by western-blotting and LysB immunodetection was 
performed using horseradish-peroxidase-conjugated anti-His monoclonal antibody (Roche). 
Lysis assay and burst size determination 
The lysis assay was performed as described in Payne et al. (2009) with some modifications. 
Briefly, M. smegmatis cells were grown in 7H9 supplemented with glucose and 1mM CaCl2 to 
an OD600 0.6-0.8. Cells were infected with phage particles at an m.o.i. of 100 and incubated for 
30 min at 37 ºC. After phage adsorption, an aliquot of 100μl was collected (T0), and incubation 
continued at 37 ºC with shaking. 150μl alliquots were collected every 30 min for 5 h. ATP 
release was measured by addition of 50 μL of ENLITEN rLuciferase/Luciferin reagent 
(Promega), and luminescence recorded in a Monolight 2010 luminometer Tecan. 
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The burst-size determination was adapted from protocols described by Adams (1959). Briefly, 
M. smegmatis cells were used in exponential growth using an m.o.i. of 1. M. smegmatis cells 
were pelleted and resuspended in 1 ml of a phage suspension (Ms6Wt or Ms6ΔLysB) supplemented 
with 1 mM CaCl2. The mixture was incubated 50 min at 37 °C to allow adsorption of the 
phages. 100 μl of 0.4% H2SO4 was added to inactivate the non-adsorbed phages and the 
incubation continued for 5 min. The suspension was neutralized with 100 μl of 0.4% NaOH and 
10 μl of infected cells were diluted in order to obtain ≤ one infected cells ml-1 in 7H9 
supplemented with 0.5% glucose and 1 mM CaCl2. Samples of 1 ml of infected culture were 
distributed in 50 tubes and incubated for 4 h at 37 °C. 200 µl of M. smegmatis cells and top agar 
(4 ml) were added to each tube and plated on 7H10. After 24 h at 37 °C, the phage plaques were 
counted and the distribution of Poisson [P(n)] was applied to determine the burst-size (BS): P 
(n) = (e-c . cn)/ n! (e < 1), where P (n) is the probability of samples having n infected cells and c 
is the average number of infected cells per tube; and BS = (total plaque count in the 50 plates) / 
(total number of infected cells). 
 
Results and Discussion 
 
Ms6 LysB is not essential for phage viability 
To better understand the contribution of LysB to the Ms6 infection cycle, we first asked whether 
it is an essential function for plaque formation. We used the Bacteriophage Recombineering of 
Electroporated DNA (BRED) strategy to delete lysB gene from the mycobacteriophage Ms6 
genome (Marinelli et al., 2008). Using this technique we were able to obtain mutant phages 
demonstrating that Ms6ΔlysB is viable (recombineering efficiency of 28%) (Fig.1) and that LysB 
is not required for plaque formation (Fig. 2).  
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Figure 1. Strategy for construction of Ms6 lysB mutants. The primers used to detected the Ms6lysBHis6 were specific 
for the hexahistidine region, that is why the Ms6 wild type was not amplified.  
Moreover, no significant differences were observed between plaques produced by Ms6wt and by 
Ms6ΔlysB (Fig. 2).  
                                                           A)                                                                                       B) 
 
 
 
 
Figure 2 Plating ability of the lysB mutant bacteriophages. A) M. smegmatis infected with Ms6wt phage; B) M. 
smegmatis infected with Ms6ΔLysB. Scale bar indicates 1 cm. 
This result is not in agreement with the one obtained for the only other LysB characterized so 
far (Payne, et. al 2009). As it happens with Ms6ΔLysB, deletion of lysB gene in 
mycobacteriophage Giles does not affect phage viability or plaque formation, however in 
contrast with these authors we did not observe a reduction in the plaque size. 
 
Effect of Ms6 LysB on phage lysis  
In order to compare the progression of phage infections of Ms6Wt and Ms6ΔlysB we measure ATP 
release which may reflect either lysis or permeabilization of the cell wall. Infection of M. 
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smegmatis with Ms6Wt and Ms6ΔlysB results in ATP release after 2h30 min, 2 h represented in the 
graphic plus 30 min of adsorption (see methods for detail). Even though we cannot observe any 
delay on the beginning of lysis, Ms6ΔlysB does not show a similar progression of infection as the 
Ms6wt (Fig. 3). Our results are not totally in agreement with the ones obtained for 
mycobacteriophage GilesΔlysB since deletion of lysB is responsible for a 30 min delay in cell 
lysis (Payne et al., 2009).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. M. smegmatis mc2155 cells were infected with Ms6Wt and Ms6ΔlysB and ATP release measured at different 
times after infection. ATP was measured in a luciferase assay and reported as relative light units (RLU).  
 
Of note is the fact that Ms6 and Giles have different lytic cassettes (Fig. 4) (Morris et al., 2008; 
Hatfull et al., 2010). The identified lysis genes in Giles genome are gp31 encoding LysA and 
gp32 encoding LysB but no holin or other lysis functions were so far assigned to any other Giles 
gene (Morris et al., 2008; Hatfull et al., 2010). In addition to the LysA, LysB and holin Ms6 
encodes Gp1, a chaperone-like protein that transports the endolysin across the cytoplasmatic 
membrane in a holin-independent manner and is required to accomplish an efficient lysis of M. 
smegmatis (Catalão et al., 2010); and Gp5, a protein with holin-like function (Catalão et al., 
2011a). At the present moment we do not know how these different cassettes contribute to the 
different phenotypes observed with Ms6ΔlysB and GilesΔlysB. 
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Figure 4. Schematic representation of mycobacteriophage Ms6 and Giles lytic cassette.  
Single-burst experiments were done to compare the viable progeny released from single cells 
infected with Ms6Wt and the Ms6ΔlysB phages. In our experimental conditions, Ms6ΔlysB yielded a 
similar burst size to what was described for Ms6Wt, an average of 149 viable phages from one 
bacterium (Catalão et al., 2010). This result is in agreement to what is observed in the plaque 
size. However, the minor ATP release observed with Ms6ΔlysB does not reflect a minor phage 
number release. At this point it is not clear how a deletion in Ms6 lysB gene affects the phage 
growth parameters; however it is noteworthy that our attempts to obtain a one-step growth curve 
were unsuccessful since we observed great variation between the results. How this reflects a 
defect in the phage release remains to be determined. 
 
LysB synthesis in the course of M. smegmatis infection 
To analyse the LysB production in M. smegmatis, the BRED strategy was also used to obtain an 
Ms6 phage with the 3’ end of lysB fused to a sequence coding for a hexahistidine tag, allowing 
the production of a LysB-His6 tagged protein. (Fig. 1). After M. smegmatis infection with 
Ms6lysBHis6, extracts were prepared from samples taken at 30 min intervals as described 
previously in materials and methods. The samples were analysed by western-blotting and LysB 
synthesis was detected with an antibody against the His6-tag. As observed in Fig. 5 LysB 
synthesis could be detected beginning at 120 min postinfection. As expected, this result is 
similar to the one obtained for LysA synthesis (Catalão et al., 2011b), since both proteins are 
transcribed into the same mRNA (Garcia et al., 2002). 
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Figure 5. Time course of LysB synthesis during Ms6lysBHis6 infection of M. smegmatis. The molecular weight in kDa 
of LysB is indicated on the left; position of LysB protein is indicated by an arrow on the right. Only the results for 30 
to 270 min postinfection are shown. 
 
The fact that genes for Rz/Rz1 equivalents are found in nearly all phages of Gram-negative 
hosts (Summer et al., 2007) indicates that for the conditions found in nature, the outer 
membrane is a significant barrier even after holin-endolysin mediated destruction of the cell 
wall. A similar point of view could be proposed for lysB-like genes that are found in nearly all 
mycobacteriophages, present in 77 out of the 81 described mycobacteriophages genomes 
(including mycobacteriophage Ms6) (Hatfull et al., 2010; Henry et al., 2010), suggesting that 
mycolylarabinogalactan layer might be a significant barrier even after the endolysin mediated 
destruction of the cell wall. It was suggested that the 4 mycobacteriophages that do not encode a 
LysB-like protein, would have evolved to utilize a host-encoded cutinase-like enzyme for this 
function (Hatfull, 2010). Although we cannot observe a delay on the lysis timing with the 
Ms6ΔlysB, this phage has a slower lysis rate. Taking in consideration that LysB is a lipolytic 
enzyme with mycolylarabinogalactan esterase activity, we cannot rule out that in nature, in 
different conditions than the ones performed in the laboratory, the absence of this protein would 
have a more accentuated impact in the Ms6 lysis profile. Of note, is the fact that for many years 
the precise role of the λ Rz/Rz1 proteins was not fully known, since under usual laboratory 
conditions, Rz/Rz1 are not required for bacteriophage λ lysis (Young & Wang, 2006). Recently, 
LysB homologues were identified in Rhodococcus equi phages (Summer et al., 2011). 
Considering that Rhodococcus and Mycobacterium share the same complex envelope, an outer 
layer composed of mycolic acids covalently linked to the peptidoglycan (Sutcliffe, 1997), it is 
anticipated that these phages should exhibit some of the features characteristic of 
mycobacteriophages, such as LysB that attacks this outer layer. However, the genetic structure 
of the lysis genes of the Rhodococcus phages differed significantly from that of the 
mycobacteriophage in that they lacked well-defined lysis gene cassettes. 
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Our present knowledge of the mechanism of bacteriophage lysis suggests that the complexity of 
phage lytic cassettes depends on their hosts. Hosts with a simpler envelope require the phage to 
possess a simple lytic cassette, whereas hosts with a complex envelope require the phage to 
have a more complex lytic cassette.  
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The results presented in this thesis allowed the characterization of the mycobacteriophage Ms6 
LysB protein and its role in Mycobacterium smegmatis lysis and allowed the following 
conclusions: 
• LysB is a lipolytic protein encoded by a gene located within the lytic cassette of a 
mycobacteriophage. This protein is able to hydrolyze both short and long-chain 
substrates, showing preference to long-chain substrates. LysB could not be classified as 
lipase or esterase, suggesting that LysB and homologous proteins could form a new 
family of lipolytic enzymes.  
• The LysB main target on the mycobacteria cell envelope is the mycolyl-arabinogalactan 
complex. LysB was characterized as a mycolyl arabinogalactan esterase since it was 
able to hydrolyze the bond between the mycolic acids and the arabinogalactan. In 
addition, LysB activity is not specific, since it can hydrolyze the TDM of M. smegmatis, 
M. tuberculosis H37Ra and M. bovis BCG 
• Even though an Ms6 mycobacteriophage defected of lysB gene was viable and the 
beginning of lysis occurs at the same time as the Ms6Wt, Ms6ΔlysB had a slower 
progression to accomplish total lysis. 
 
This work represents a step forward in understanding the mechanisms involved in the 
mycobacteriophage lysis. It was described, for the first time, a gene within the lytic cassette of 
the mycobacteriophage Ms6, which encodes an enzyme with lipolytic activity. The starting 
point for this work was the presence of a conserved pentapeptide motif characteristic of lipolytic 
enzymes which lead us to search for lipolytic activity. Since lipolytic enzymes include 
carboxylesterases and true lipases (Arpigny & Jaeger, 1999), activity of the recombinant protein 
His6-LysB was tested on plate assays with esterase and lipase specific substrates. LysB was able 
to hydrolyze tributyrin, Tween 20 and Tween 80 (esterase substrates) as well triolein and 
rhodamine B (true lipase substrates). Another evidence of true lipase activity was obtained with 
the release of resorufin from the triglyceride 1,2-O-dilauryl-rac-glycero-3-glutaric acid 
resorufin ester. More specific assays with a wide range of p-nitrophenyl fatty acid esters were 
performed and LysB showed activity with all substrates tested, demonstrating a higher affinity 
for pNP esters of longer chain length (C16 and C18). These results, together with the higher 
catalytic efficiency revealed for C12 and C14 pNP esters, indicate that the long chain substrates 
must represent the natural substrate of LysB, suggesting that this enzyme could be classified as 
a lipase. However, the amino acid sequence of LysB does not show the characteristic features of 
any of the lipases families described so far (Arpigny & Jaeger, 1999). LysB conserved 
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pentatpeptide (Gly-Tyr-Ser-Gln-Gly) resembles the pentapeptide described in most cutinases, 
nevertheless LysB amino acid sequence lacks the pattern described around the conserved motif 
(Parker et al., 2007). Several conserved block of amino acids were identified on LysB and 
mycobacteriophage homologous proteins. These observations together with the fact that it was 
not possible to group LysB and putative proteins on any other lipolytic enzyme family, lead us 
to suggest that they might be part of a new family of lipolytic enzymes. 
In addition, conserved potential amino acids residues involved in the catalytic triad were also 
observed in the amino acid sequence alignment between Ms6 LysB and its homologous 
proteins. Substitutions of Ser168 (located at the center of the pentapeptide GXSXG), Asp215 
and His246 by an Alanine resulted in a decrease of the enymatic activity, indicating that those 
amino acids are involved in catalysis. The involvement of Serine in the LySB activity was 
further strengthened by the decreased in enzyme activity after treatment with PMSF, a serine 
protease inhibitor. The results demonstrated that Ser168 is part of the catalytic triad, since 
almost no activity was observed on both assays and that Ms6 LysB belongs to the family of 
serine hydrolases, as is the case of lipid hydrolases (Holmquist, 2000). 
One can question what would be the role of a lipolytic enzyme in cell lysis. Since lysB gene was 
located within the lytic cassette of mycobacteriophage Ms6, and since LysA was already 
identified as an amidase, together with the fact that 60% of the mycobacteria cell wall is 
composed of lipids (Brennan & Nikaido, 1995) LysB activity was tested towards the lipid layer 
of M. smegmatis. After treatment of M. smegmatis mAGP with LysB it was observed an 
increase in free mycolic acids by LC-MS. These results demonstrated that LysB was able to 
hydrolyze ester bonds that are necessary for the integrity of the mycobacterial envelope which is 
in agreement with the work performed by Payne et al., (2010), where the authors demonstrated 
that LysB from the mycobaceriophage Giles has mycolyl arabinogalactan esterase activity. Even 
though these homologous proteins share a low identity within the amino acid sequence (15% of 
identity), they have in common the conserved motif GXSXG of lipolytic enzymes (Hatfull et 
al., 2006; Gil et al., 2010), and share the conserved amino acids Asp and His suggesting a 
common function and thus a common substrate for them. Until very recently, lysB homologues 
were only found within mycobacteriophage lysis cassettes. Summer et al., (2010) identified for 
the first time LysB-like proteins in phages that infects Rhodococcus equi. One of the features 
that Rhodococcus shares with Mycobacterium is the presence of an outer layer composed of 
mycolic acids covalently linked to the peptidoglycan (Sutcliffe, 1998). This layer presents an 
additional challenge to phages infecting the mycolata group, both in terms of adsorption and 
DNA injection process as well as host cell lysis. One can hypothesize that to overcome this 
barrier mycobacteriophages encode LysB equivalents and the same can be anticipated for 
Concluding Remarks 
 
phages that infect other members of the Corynebacterineae suborder, including Rhodococcus, 
which would also carry genes encoding LysB equivalents (Summer et al., 2010).  
In addition to a mycolyl arabinogalactan esterase acitvity, Ms6 LysB also acts on other lipids 
containing mycolic acids. It was shown that after treatment of M. smegmatis total lipids, one 
other lipid was affected by LysB activity. Structural analysis identified the lipid as the 
mycobacterial TDM, which is composed by two mycolic acids molecules bound to a trehalose 
molecule by an ester bond. After LysB activity, free mycolic acids and free trehalose molecules 
were identified, indicating that LysB hydrolyzed the ester bond of the TDM. Nevertheless, due 
to the importance of the mAGP-complex on stability of the mycobacteria cell envelope it seams 
reasonable to considerer that the cleavage of the mycobacterial outer membrane from the 
peptidoglycan-arabinogalactan layer is the primary role of LysB. In contrast to what happens 
with most of the described endolysins which, are highly specific towards their hosts (Loessner, 
2005), LysB is not specific, since it hydrolyses the TDM from both fast and slow growing 
mycobacteria, like M. tuberculosis and M. bovis BCG.  
 
After characterizing LysB as a lipolytic enzyme and demonstrating that its natural substrate is 
the mycolyl-arabinogalactan complex, the next step was to understand the role of this protein 
during mycobacteriophage life cycle. An Ms6 derivative mutant, lacking lysB gene was shown 
to be viable, indicating that LysB is not essential for plaque formation. Although phage release 
can be detected at the same time as the Ms6Wt, Ms6ΔlysB appears to have a slower phage release 
rate, indicating that accomplish total lysis later than the wild type.  
Ms6ΔlysB can destroy the peptidoglycan because it still produces the endolysin, but without LysB 
the mash of lipids that are not hydrolysed certainly difficult the phage release, resulting in a 
delay of phage release. Taking in consideration all the above LysB characteristics, one could 
have hypothesized that lysB deletion would have a greater impact in Ms6 lysis parameters (burst 
size, plaque size and lysis timing). However, we cannot rule out that in nature, in different 
conditions than the ones reproduced in a laboratory environment, this protein would have a 
more significant role during Ms6 infection. Our results are not completely similar to the ones 
obtained for the only other LysB protein described so far (Payne et al., 2009) but it must be 
taken in consideration that the lytic cassettes of both mycobacteriophages are different, and so 
far we do not know how the additional genes can impact on the mycobacteriophages lysis. 
Mycobacteria are considered to be Gram-positive bacteria, however the existence of the 
mycobacterial outer membrane composed of mycolic acids and free lipids presents a barrier 
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analogous to the outer membrane of Gram-negative bacteria (Hoffmann et al., 2008; Zuber et 
al., 2008). Analogies can be made between the function of LysB against the mycobacterial outer 
membrane with the lambda Rz/Rz1 homologues of Gram-negative hosts, which mediate the 
final step of host lysis by fusing the inner and outer membranes (Berry et al., 2008; Payne et al., 
2009; Summer et al., 2007). So, bacteriophages infecting mycobacteria may also need 
additional lysis genes to accomplish lysis. Due to the complexity of the cell wall of 
mycobacteria, it is easy to understand why a mycobacteriophage would developed an alternative 
solution, a lipolytic enzyme, to compromise the mycobacterial outer membrane by 
compromising its linkage to the arabinogalactan-peptidoglycan layer, in order to meet one the 
principles of phage lysis mentioned by Ry Young: ‘the lysis process, once initiated, should be 
rapid in order to improve phage production’ (Young, 2005).  
The sequence analysis of 81 mycobacteriophage genomes (Hatfull et al., 2010; Henry et al., 
2010) revealed that 77 mycobacteriophages encode a LysB-like protein, which demonstrates the 
importance of the protein throughout the mycobacteriophage evolution indicating that the 
mycolyl arabinogalactan layer is a significant barrier even after the endolysin mediated 
destruction of the cell wall. Thus, we propose that LysB activity, together with LysA acting on 
the peptidoglycan results in a more efficient breakage of the cell wall, allowing a robust 
dissemination of the new phage particles. Of note are the four mycobacteriophages (Che12, 
Rosebush, Qyrzula and Myrna) that lacks a LysB-like protein. A hypothesis is that these phages 
have evolved a mechanism for utilizing a host-encoded cutinase-like enzyme for this function 
(Hatfull, 2010). 
At this time it is unknown how Ms6 LysB is localized to its substrate, since no signal sequences 
allowing its transport across the cell barriers have been identified (Gil et al., 2008). Since Ms6 
LysA access to the peptidoglycan is not holin dependent, but in fact is the Ms6 Gp1 chaperone 
that leads LysA to it substrate, it would be interesting to see if LysB is also dependent on the 
Gp1 chaperone to access the lipid layer after the peptidoglycan. Recently, our group 
demonstrated the LysA antibacterial activity when added to several mycobacteria species 
(Catalão et al., 2011a). It would be interesting to see if the combination of LysA and LysB 
would have an increased effect since when Ms6 LysB alone is added from the outside, it is 
unable to disrupt the outer membrane sufficiently to kill the mycobacteria (unpublish 
observation) but when LysA is added from the outside . 
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